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Muy tarde por la noche el Mullah Nasrudin se encuentra dando 
vueltas alrededor de una farola, mirando hacia abajo. Pasa por 
allí un vecino. 
—¿Qué estás haciendo Nasrudín, has perdido alguna cosa? 
—Sí, estoy buscando mi llave. 
El vecino se queda con él para ayudarle a buscar. Después de un 
rato, pasa una vecina. 
—¿Qué estáis haciendo? —les pregunta. 
—Estamos buscando la llave de Nasrudín. 
Ella también quiere ayudarlos, así que se pone a buscar. Luego, 
otro vecino se une a ellos y juntos buscan, buscan y buscan. 
Habiendo buscado durante un largo rato acaban por cansarse y 
un vecino pregunta: 
—Nasrudín, hemos buscado tu llave durante mucho tiempo, 
¿estás seguro de haberla perdido en este lugar? 
—No, dice Nasrudín 
—¿dónde la perdiste, pues? 
—Allí, en mi casa. 
—Entonces, ¿¡por qué la estamos buscando aquí!? 
—Pues porque aquí hay más luz, mi casa está muy oscura. 
... 
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 RESUMEN 
La neocorteza (comúnmente conocida como corteza cerebral) es la estructura más compleja 
y recientemente evolucionada del cerebro de mamíferos. Contiene cientos de tipos celulares 
ensamblados en sofisticados circuitos neurales que –integrando información del mundo interno 
y externo– posibilitan las extraordinarias capacidades cognitivas, sensoriales y motoras que nos 
hacen humanos, desde los precisos y delicados movimientos de un músico virtuoso al intrincado 
procesamiento verbal y emocional necesario para la poesía. 
La organización básica de la corteza cerebral es producto de la formación de patrones durante 
el desarrollo embrionario. Dicha información está codificada en el genoma y es expresada 
mediante conservadas redes de regulación génica que dirigen la construcción de la estereotipada 
arquitectura cortical en el feto en desarrollo. Hoy en día, se cree que una gran proporción de 
trastornos neuropsiquiátricos –como las epilepsias refractarias, autismo o esquizofrenia– 
tienen su origen en el desarrollo cerebral embrionario. Por lo tanto, realizar una disección de 
los determinantes intrínsecos que subyacen al desarrollo cortical –en condiciones normales y en 
ciertas patologías– es una provechosa manera de comprender en profundidad la corteza cerebral 
per se, así como de ofrecer oportunidades terapéuticas a aquellos que sufren de patologías del 
neurodesarrollo. 
La planta Cannabis sativa (conocida como marihuana) ha sido cultivada por el ser humano, 
con diferentes propósitos, desde el Neolítico. El compuesto psicoactivo más prominente del 
cannabis es el Δ9-tetrahidrocannabinol (THC), cuyos efectos están mediados por su principal 
diana molecular, el receptor cannabinoide CB1 (CB1R). CB1R es muy abundante en el cerebro y 
muchos otros órganos, donde ejerce acciones pleiotrópicas en el control del metabolismo celular, 
fisiología y función. Este, junto a un segundo (CB2) receptor, sus ligandos endógenos así como 
las enzimas responsables de su síntesis y degradación conforman lo que se llama el Sistema 
Endocannabinoide (SEC). 
El SEC, además de su conocido papel en la fisiología adulta de mamíferos, está presente y 
modula aspectos clave a lo largo de todo el desarrollo cerebral embrionario. Se ha visto que modula 
la motilidad del esperma y la maduración del oocito o el proceso de fertilización e implantación del 
óvulo fecundado. Más adelante, CB1R regula una plétora de eventos del desarrollo cortical, desde 
la proliferación y destino de progenitores neurales hasta la migración neuronal, especificación de 
motoneuronas corticoespinales (MNCS) y la morfogénesis final de neuronas de proyección. 
El cannabis es, de lejos, la droga ilícita más ampliamente consumida en países occidentales, 
con especial prevalencia en mujeres gestantes. Hay profusa literatura científica sobre las 
consecuencias del consumo materno de cannabis en la descendencia, que incluyen déficits 
cognitivos o un aumento de la susceptibilidad a desarrollar trastornos neuropsiquiátricos como 
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la esquizofrenia, depresión o ansiedad. No obstante, en la mayoría de los casos, el sustrato celular 
y molecular que subyace a los defectos producidos por exposición prenatal a cannabinoides, así 
como las consecuencias funcionales de una disfunción embrionaria del SEC son ampliamente 
desconocidos. 
Es por esto que una caracterización precisa de los aspectos del desarrollo fuertemente 
influenciados por CB1R y el SEC, además del impacto neurobiológico en la progenie de una 
disfunción embrionaria del SEC –causada por variaciones genéticas o por influencias ambientales 
como el consumo materno de marihuana– es una cuestión fundamental y sirve como marco 
conceptual para esta Tesis Doctoral. 
En este contexto, hemos definido los siguientes objetivos para esta Tesis Doctoral: 
Objetivo 1 . Investigar el papel del SEC en el proceso de migración radial de neuronas piramidales 
durante el desarrollo cortical y evaluar las alteraciones celulares y funcionales a largo plazo 
derivadas de una disfunción de CB1R restringida al embrión. 
Los resultados correspondientes han sido publicados en el siguiente artículo científico: 
Díaz-Alonso J*, de Salas-Quiroga A*, Paraíso-Luna J, García-Rincón D, Garcez P, Parsons M, Andradas 
C, Sánchez C, Guillemot F, Guzmán M and Galve-Roperh I. (2016) ‘Loss of Cannabinoid CB1 Receptors 
Induces Cortical Migration Malformations and Increases Seizure Susceptibility’. Cereb. Cortex 1-15. 
Objetivo 2 . Dilucidar el sustrato neurobiológico de la acción del Δ9-THC durante el desarrollo 
embrionario cortical. En particular, explorar el impacto de la administración prenatal de este 
cannabinoide en la diferenciación neuronal, con especial atención a la especificación de MNCS. 
Los resultados correspondientes han sido publicados en el siguiente artículo científico: 
de Salas-Quiroga, A.*, Díaz-Alonso, J.*, García-Rincón, D., Remmers, F., Vega, D., Gómez-Cañas, M., 
Lutz, B., Guzmán, M., and Galve-Roperh, I. (2015) ‘Prenatal exposure to cannabinoids evokes long-lasting 
functional alterations by targeting CB1 receptors on developing cortical neurons’. Proc. Natl. Acad. Sci. 
USA, 112(44), 13693–13698. 
Para abordar el Objetivo 1 de esta Tesis, trabajando con ratones, llevamos a cabo el 
knockdown transitorio de CB1 con siRNA en neuronas piramidales recién generadas para revelar 
el impacto de la pérdida de función de CB1 restringida y a corto plazo en la migración radial de
neuronas de proyección y los déficits funcionales potenciales en la edad adulta. Observamos un 
bloqueo de la migración que conllevó fuertes alteraciones a largo plazo en el posicionamiento 
de las neuronas corticales, la formación de heterotopías neuronales y un incremento de la 
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susceptibilidad a desarrollar crisis epilépticas en ratones adultos. Análisis celulares y bioquímicos 
mostraron que la pérdida de función de CB1R llevaba a una acumulación aberrante de la GTPasa 
RhoA –crítica en el control del citoesqueleto de actina– en neuronas piramidales, que por tanto 
perjudicó la morfología de las neuronas migrantes. Notablemente, los déficits desencadenados 
por la disfunción de CB1R fueron completamente rescatados por el knockdown concomitante de 
RhoA. 
En suma, nuestros resultados allanan el camino hacia una mejor comprensión de rol 
fisiológico del SEC en el cerebro en desarrollo y proveen una perspectiva mecanística sobre 
las Malformaciones del Desarrollo Cortical (MDC) causadas por alteraciones de la migración 
neuronal. 
Alternativamente, al respecto del Objetivo 2 de esta Tesis, modelizamos un consumo 
prenatal de cannabis en ratón para identificar el preciso sustrato del neurodesarrollo responsable 
de las alteraciones funcionales producidas por exposición a THC evidentes en el adulto. La 
administración de THC se llevó a cabo durante una ventana temporal restringida del desarrollo 
embrionario, coincidente con el periodo más activo de generación de neuronas de la corteza 
cerebral que condujo a una regulación a la baja del receptor. Significativamente, observamos un 
fallo en la generación de MNCS que se correlacionaba con alteraciones a largo plazo de la función 
motora fina y un incremento de la susceptibilidad a epilepsia. Para valorar la implicación de CB1R 
en dicho fenotipo, empleamos ratones deficientes en CB1 de manera constitutiva, que resultaron 
resistentes a las alteraciones observadas dependientes de THC. A continuación, mediante el 
uso de una estrategia de rescate de la expresión de CB1, mediada por la recombinasa Cre de 
manera selectiva de linaje celular, en ratones desprovistos de CB1, fuimos capaces de rescatar 
selectivamente los déficits en el desarrollo de MNCS característicos de ratones carentes de CB1 y, 
a su vez, restablecimos por completo la susceptibilidad a las alteraciones celulares y funcionales 
dependientes de THC en la descendencia adulta. 
Por otro lado, observamos que la exposición prenatal a THC indujo un incremento en la 
susceptibilidad a convulsiones mediado por CB1Rs presentes tanto en neuronas piramidales del 
telencéfalo dorsal como en neuronas GABAérgicas prosencefálicas. 
Por tanto, podemos concluir que afectar a CB1Rs presentes en una población neuronal 
determinada y una particular ventana temporal del desarrollo embrionario con el más abundante 
y prominente compuesto psicoactivo del cannabis puede desencadenar importantes alteraciones 
neurológicas en la descendencia. 
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 ABSTRACT 
The neocortex (commonly referred to as cerebral cortex) is the most complex and recently 
evolved structure in the mammalian brain. It contains hundreds of cell-types assembled into 
sophisticated neural circuits that –by integrating information from the external and internal 
world– enable the extraordinary cognitive and sensorimotor capacities that make us human, 
from the delicate and precise movements of a music virtuoso to the intricate verbal and emotional 
processing required for poetry. 
The basic organization of the cerebral cortex is a product of developmental pattern formation, 
whose information is encoded in the genome and expressed by conserved genetic regulatory 
networks, which direct the construction of the stereotyped cortical architecture in the developing 
fetus. Nowadays, it is believed that a large proportion of neuropsychiatric disorders –as refractory 
epilepsies, autism or schizophrenia– have their origin in embryonic brain development. Therefore, 
dissecting the intrinsic determinants underlying –normal and abnormal– cortical development is 
a helpful path to fully comprehend the cerebral cortex itself and to offer therapeutical possibilities 
to those who suffer from neurodevelopmental pathologies. 
The plant Cannabis sativa (commonly known as marijuana) has been cultivated, with 
several purposes, by humans since Neolithic times. The most prominent psychoactive compound 
of cannabis is the Δ9-tetrahydrocannabinol (THC), whose effects are mediated by its main 
molecular target, the CB1 cannabinoid receptor (CB1R). CB1R is strikingly abundant in the brain 
and many other regions of the body, where it exerts pleiotropic actions in the control of cell 
metabolism, physiology and function. This, along with a second (CB2) receptor, their endogenous 
ligands and the enzymes responsible of their synthesis and degradation conform the so-called 
Endocannabinoid System (ECS). 
The ECS, in addition to its well-known roles in adult mammalian physiology, is present and 
modulate key events throughout embryonic brain development. It has been shown to regulate 
sperm cell motility, oocyte maturation or the process of fertilization and implantation. Later, 
CB1R regulates a plethora of cortical developmental steps, ranging from neural progenitor cell 
proliferation and fate acquisition to neuronal migration, corticospinal motorneuron (CSMN) 
specification and eventual morphogenesis of projection neurons. 
Cannabis is, by far, the most widely used illicit drug in Western countries, with a remarkable 
prevalence by pregnant women. There is profuse literature about the functional consequences 
of maternal cannabis use on the offspring, which include cognitive impairments and increased 
susceptibility to develop neuropsychiatric disorders such as schizophrenia, depression or anxiety. 
Nevertheless, in most cases, the particular molecular and cellular substrate underlying canna­
binoid-dependent alterations, as well as the functional outcome of embryonic ECS dysfunction 
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are mostly unknown. Hence, a precise characterization of the developmental events deeply 
influenced by CB1R and the ECS, and the long-lasting neurobiological impact of developmental 
ECS malfunction in the adult progeny –caused by genetic variations or environmental insults 
such as prenatal marijuana exposure– is a major concern as serves as the conceptual framework 
for this Doctoral Thesis. 
In this context, we defined the following Aims for this Doctoral Thesis: 
Aim 1 . To investigate the role of the ECS in the process of radial migration of newborn pyramidal 
neurons during cortical development and to evaluate long-lasting functional alterations derived 
of developmentally-restricted CB1R dysfunction. 
The corresponding results have been published in the following paper: 
Díaz-Alonso, J.*, de Salas-Quiroga, A.*, Paraíso-Luna, J., García-Rincón, D., Garcez, P., Parsons, M., 
Andradas, C., Sánchez, C., Guillemot, F., Guzmán, M. and Galve-Roperh, I. (2016) ‘Loss of Cannabinoid 
CB1 Receptors Induces Cortical Migration Malformations and Increases Seizure Susceptibility’. Cereb. 
Cortex [Epub ahead of print]. 
Aim 2. To elucidate the neurobiological substrate of Δ9-THC actions during embryonic 
cortical development. Particularly, to explore the impact of prenatal administration of this 
phytocannabinoid on neuronal differentiation, with special attention to CSMN specification. 
The corresponding results have been published in the following paper: 
de Salas-Quiroga A*, Díaz-Alonso J*, García-Rincón D, Remmers F, Vega D, Gómez-Cañas M, Lutz B, 
Guzmán M, and Galve-Roperh I. (2015) ‘Prenatal exposure to cannabinoids evokes long-lasting functional 
alterations by targeting CB1 receptors on developing cortical neurons’.  Proc. Natl. Acad. Sci. USA, 112(44), 
13693–13698. 
To address the Aim 1 of this Thesis, working with mice, we performed transient 
siRNA-mediated CB1 knockdown in newborn pyramidal neurons to reveal the impact of 
developmentally restricted, short-term CB1 loss of function on radial migration of projection 
neurons and its potential functional deficits in adulthood. We observed a migration arrest that led 
to profound and long-lasting alterations in cortical neuron positioning, the formation of neuronal 
heterotopias and increased seizure susceptibility in adult mice. Cellular and biochemical analyses 
showed that loss of CB1R function led to abnormal accumulation of the GTPase RhoA –critical 
for the control of actin cytoskeleton– in newborn pyramidal neurons thereby disrupting the 
morphology of migrating cells. Remarkably, migration deficits elicited by CB1R dysfunction were 
fully rescued by concomitant RhoA knockdown. 
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Collectively, our findings pave the way toward a better understanding of the physiological 
role of the ECS in brain development and provide relevant molecular mechanistic insights into 
Malformations of Cortical Development (MCD) caused by altered neuronal migration. 
Alternatively, regarding theAim 2 of this Thesis, we modeled prenatal cannabis consumption in 
mice to identify the particular neurodevelopmental substrate responsible for cannabinoid-induced 
functional alterations that remain overt in adulthood. Administration of THC was conducted 
during a restricted embryonic time window, coinciding with the active period of neuron generation 
in the cerebral cortex that induced a downregulation of the receptor. We found an impairment 
in CSMN generation that correlates with long-lasting skilled motor functional alterations and 
susceptibility to epilepsy. To unequivocally assess the role of CB1R signaling in THC-induced 
alterations, we employed constitutive CB1-deficient mice, which were resistant to THC-induced 
developmental alterations. Next, by using a Cre recombinase-mediated, lineage-specific, CB1
expression-rescue strategy in a CB1-null background, we were able to selectively rescue the 
deficits in CSMN development characteristic of CB1-deficient mice and, in turn, fully restore the 
susceptibility to embryonic THC-induced cellular and functional deficits in adulthood. 
Furthermore, we also found that prenatal THC exposure induced an increase in seizure 
susceptibility that was mediated by CB1Rs present in both developing dorsal telencephalic 
pyramidal neurons and forebrain GABAergic neurons. 
Hence, targeting CB1Rs with the most prominent marijuana-derived psychoactive compound 
in a particular neuronal population and time frame during embryonic development can evoke 
remarkable long-lasting neurological alterations in the offspring. 
11 
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More than a century ago, the seminal work accomplished by Santiago Ramón y Cajal contributed 
to the recognition that the neuron was the fundamental brick of the brain. His research set the 
basis to understand, at the cellular level, how brain’s structure is related to its complex function, 
giving rise to the field of neuroscience (Ramón y Cajal 1899; Ramón y Cajal 1909). Since then, 
astonishing advances have been made to unveil the genetic, molecular, cellular, anatomical and 
functional logic that underlies our most intriguing organ, although it is still far from understood. 
The neocortex (commonly referred to as cerebral cortex) is the most complex and recently 
evolved structure in the mammalian brain. It contains hundreds of cell-types assembled into 
sophisticated neural circuits that, by integrating information from the external and internal world, 
enable the extraordinary cognitive and sensorimotor capacities that make us human. The cerebral 
cortex is essential for the consciousness and empowers sublime behaviors such as the delicate and 
precise movements of a music virtuoso or the intricate verbal and emotional processing required 
for poetry. 
The human neocortex is a 3-4 mm thick, highly convoluted sheet of tissue with an approximate 
surface of 26 m2. It contains ~16 x 109 neurons –and more than three times of glial cells– 
(Herculano-Houzel 2009; Azevedo et al. 2009) connected to each other by an estimated number 
of synapses of ~164 x 1012 within the cerebral cortex (Tang et al. 2001), what allows a virtually 
infinite computing potential (Grillner 2006; Bartol et al. 2015). 
Neuronal number and diversity is at the core of brain function, where complex circuitries 
may be largely simplified as hierarchical networks of excitatory and inhibitory neurons. The 
cerebral cortex is mainly comprised of excitatory glutamatergic pyramidal neurons and inhibitory 
gamma-aminobutyric acidergic (GABAergic) interneurons highly organized into layers (I-VI) 
and columns. Roughly, most neurons present in one layer share overall connectivity patterns 
whereas those localized within the same column are typically interconnected across layers, what 
represents the functional unit of the cerebral cortex (Mountcastle 1957; Rakic 1988; Mountcastle 
1997; Markram et al. 2015). These cortical columns are organized into functional modules 
specialized to operate certain tasks. It is conceivable that vertebrate’s evolution has developed 
an extraordinary mechanism, a scalable functional architecture which –by amplifying and 
combining these functional templates– allows to adapt to such a variety of lifestyles and their 
corresponding challenges (Huang 2014; Hofman 2014). Pyramidal cells, which account for ~80% 
of the neuronal population in the cerebral cortex, usually extend long axons and are specialized in 
dispatching information between different cortical areas as well as to distant regions of the brain, 
hence they are also known as projection neurons (PNs). Cortical interneurons, in turn, establish 
local neuronal assemblies where, by coordinated inhibitory inputs, synchronize the firing of 
pyramidal cells and orchestrate electric functional oscillations (Ascoli et al. 2008; Buzsáki et al. 
2012; Defelipe et al. 2013) (Figure 1). An appropriate balance between excitation and inhibition 
is essential for maintaining normal brain function and, consequently, crucial developmental and 
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Figure 1 . Graphic representation of the cortical column functional unit . (A) Neuron densities and numbers. (B) Neuronal 
fractions in a cortical column. DAPI labels all cells (blue). NeuN labels all neurons (green), GABA labels all GABAergic cells including 
glia (red), dual GABA+/NeuN+ cells depict interneurons. Bars to the right show fractions of excitatory (red) and inhibitory (blue) 
neurons in each layer. (C) Simplified schematic representation of the neocortical microcircuitry, including major cell types and their 
afferencies and efferencies. Excitatory (red) and inhibitory (blue) cells and synaptic connections are shown. ChC, Chandelier cell; BCs, 
basket cells; DBCs, double-bouquet cells; BPs, bipolar cells; NGCs, neurogliaform cells; MNCs, Martinotti cells;CRCs, Cajal-Retzius 
cells; Bs, brainstem; SC, spinal cord; BG, basal ganglia (BG); TH, thalamus; CL, claustrum; SSC, spiny stellate cell; WM, white matter. 
Adapted from Markram et al., 2015 and Huang, 2014. 
physiological mechanisms have evolved to safeguard this dynamic equilibrium. 
It is convenient to note that, given the obvious ethical limitations to study the human central 
nervous system (CNS) at a profound level, what inevitably implies its manipulation, the great 
majority of our knowledge about brain’s structure and physiology is coming from animal models. 
There is a wide spectrum of models used for research purposes which mainly depend on the level 
of complexity or the aim of the project, thus the fruit fly Drosophila melanogaster or the nematode 
Caenorhabditis elegans may be well-suited models for investigating highly conserved molecular 
mechanisms whereas for studying cognitive or social behaviors is frequent the use of rats or even 
monkeys. For the purposes of this Thesis, the mouse (Mus musculus) was used as animal model 
for almost the totality of the experiments performed. Despite the limitations from a translational 
perspective, this model provides very useful genetic tools to study mammalian brain development 
as well as a nourished conceptual frame given the deep knowledge that currently exists about its 
biology and its extended use in worldwide labs. 
1. CEREBRAL CORTEX DEVELOPMENT 
The basic organization of the cerebral cortex is a product of developmental pattern formation, 
whose information is encoded in the genome and expressed by conserved genetic regulatory 
networks, which direct the construction of the stereotyped cortical architecture in the developing 
fetus. Therefore, dissecting the intrinsic determinants underlying –normal and abnormal– 
cortical development is a helpful path to fully comprehend the cerebral cortex itself. 
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Despite the vast complexity of the adult CNS, it all begins as a simple neuroepithelium from a 
specialized region of the dorsal ectoderm, the neural plate. Early in development –at embryonic 
day 8.5 (E8.5) in the mouse– the neural plate undergoes a process termed neurulation, which 
consists in the shaping, folding and midline fusion of the neural plate, resulting in an outside-in 
hollow tube that extends along the longitudinal axis of the embryo and will generate the brain and 
spinal cord (Copp et al. 2003). Hereafter commences a topographic compartmentalization of the 
neural tube, where the rostrocaudal and dorsoventral axis are determined by precisely controlled 
gradients of morphogens that induce specific arrays of transcription factors (Rubenstein et al. 
1998; Puelles & Rubenstein 2003; Hébert & Fishell 2008). This process results in the formation 
of the primary vesicles: prosencephalon, mesencephalon and rhombencephalon, the embryonic 
primordia of the forebrain, midbrain and hindbrain, respectively. The cerebral cortex specializes 
from the dorsal part of the telencephalon, the rostral-most end of the neural tube, that along with the 
diencephalon –which gives rise to thalamic and hypothalamic nuclei– outline the prosencephalon 
(Rallu et al. 2002; O’Leary et al. 2007) (Figure 2A). Following these early patterning events, by 
E10.5, the embryonic telencephalon is grossly divided into a dorsal ventricular zone or pallium 
and a subpallium or a series of ventral ganglionic eminences –lateral (LGE), medial (MGE) and 
caudal (CGE)– positioned along the rostrocaudal axis (Figure 2B). Each of these domains contains 
a proliferative compartment directly apposed to the cerebral ventricle and produces the various 
types of cells that eventually result in the mature telencephalon. The pallium generates three 
distinct structures in the adult brain: the neocortex, the archicortex (entorhinal and retrosplenial 
cortices, subiculum and hippocampus) and the paleocortex (olfactory piriform cortex). The 
subpallium, in turn, is responsible for the development of the basal ganglia and almost the totality 
of the forebrain GABAergic interneurons (Hansen et al. 2013; Huang 2014; Marín & Müller 
2014). Noteworthy, this scenario might differ among species, since it has been proposed a pallial 
proliferative niche contributing to some subclasses of cortical interneurons in humans and other 
primates (Radonjić et al. 2014). 
A B 
Figure 2 . Main subdivisions of the embryonic mouse brain and gene expression in the telencephalon . (A) Side view of 
a mouse brain at around E10, showing the main compartmets. (B) Gene expression patterns in the telencephalon. Drawings of medial, 
intermediate and caudal coronal sections of E13.5 mouse brain showing the expression patterns of main transcription factors.  Pax6 
is predominant in the pallium, whereas Dlx2 or Nxk2.1 are characteristic of subpallial domains. Adapted from Rallu et al., 2002 and 
Hernández-Miranda et al. 2010. 
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In the mouse, the entire embryonic development takes around twenty days, but the majority of 
neurons are born within the last week of gestation. During these days are settled the basis of the 
radial and tangential organization of the neocortex, following the theoretical framework 
established by the ‘proto-map and radial unit hypothesis’ that, decades ago, made an effort to 
reconcile available data on these two organizational axes of the cortex (Rakic 1988). According to 
this hypothesis; “the ependymal layer of the embryonic cerebral ventricle consists of proliferative 
units that provide a proto-map of prospective cytoarchitectonic areas. The output of the 
proliferative units is translated via glial guides to the expanding cortex in the form of ontogenetic 
columns, whose final number for each area can be modified through interaction with afferent 
input” (Figure 3). 
Figure 3 . Representation of the ‘proto-map 
and radial unit hypothesis’ . A three-dimensional 
illustration of the developmental events occurring 
during early stages of corticognesis in the monkey. The 
drawing illustrates radial migration which underlies 
its columnar organization. After their last division, 
cohorts of migrating neurons (MN) traverse the 
intermediate zone (IZ) and the subplate (SP) where 
they may interact with afferents arriving sequentially 
from the nucleus basalis (NB), the monamine nuclei 
of the brainstem (MA), from the thalamic radiation 
(TR), and from several ipsilateral and contralateral 
corticocortical bundles (CC). Newly generated neurons 
bypass those generated earlier, and settle at the 
interface between the developing cortical plate (CP) 
and the marginal zone (MZ) in an inside-out fashion. 
Although some cells may detach from the cohort and 
move laterally, guided by an axonal bundle, most are 
gliophilic, have affinity for the glial surface, and obey 
the constraints imposed by transient radial glial (RG) 
cell scaffolding. This cellular arrangement preserves 
the relationship between the proliferative mosaic of 
the ventricular zone (VZ) and the corresponding map 
within the SP and CP, even though the cortical surface 
in primates shifts considerably during the massive 
cerebral growth in the mid-gestational period. The 
numerals refer to corresponding units in the VZ and 
CP. From Mountcastle, 1997. 
1.1. Cortical progenitor diversity 
The idea that the organization of the mature cortex depends on the proliferation of germinal cells 
lining the embryonic ventricles was cast by Wilhelm His as early as in the late 19th century (His 1874; 
Allen 1912). Nevertheless, it was not until the development of labeled analogs of thymidine (first 
H3-thymidine and later halogen-labeled deoxyuridines as BrdU) that this theory was confirmed 
and led, one century later, to set a uniform nomenclature for neurogenic compartments by the 
Boulder Committee (The Boulder Committee 1970). In that revision, the committee proposed the 
following terms for the four fundamental cortical embryonic zones according to the form, behavior, 
and fate of its constituent cells: ventricular (VZ), subventricular (SVZ), intermediate (IZ) and 
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 marginal (MZ) zones. Moreover, the VZ and SVZ are the mitotically active compartments where 
are located the embryonic cortical progenitors that give rise to most neurons and glia present in 
the mature cortex. There are several classes of cortical progenitors, regarding their morphological 
and spatiotemporal characteristics, their molecular profile or neurogenic fate (Kriegstein & 
Alvarez-Buylla 2009; Taverna et al. 2014; De Juan Romero & Borrell 2015). However, this is a 
changing topic subjected to intense study and debate, since progenitor populations vary among 
species and there are different hypothesis regarding their identity, location, dynamics and cell­
fate pluripotency (Lui et al. 2011; Franco et al. 2012; Eckler et al. 2015; De Juan Romero & Borrell 
2015). Nonetheless, we may roughly determine three –sequentially related– main classes of 
cortical progenitors during mouse development: neuroepithelial cells (NECs), apical progenitors 
or radial glia cells (RGCs) and basal or intermediate progenitors (IPs) (Figure 4). 
1.1.1. Neuroepithelial cells 
At early stages of cortical development, the telencephalic vesicle is uniformly composed of a 
simple neuroepithelium formed by elongated, bipolar cells spanning the entire thickness of the 
telencephalic wall (Sidman & Rakic 1973). NECs undergo a process called interkinetic nuclear 
migration (IKM), namely cell divisions take place in the apical –in contact to the ventricle– side of 
the telencephalic wall whereas during G1 they translocate their soma to the basal side to undergo 
Figure 4. Major classes of cortical progenitors in mouse cortical development . The image schematizes the overall 
corticogenesis process and represents the transition between the main types of cortical progenitors (NECs, RGCs and IPs) and their 
respective developmental cortical compartments. IPs are segregated into neuronal IP cells (nIPCs) and oligodendroglial IP cells 
(oIPCs), which give rise to neurons and oligodendrocytes, respectively. CP cortical plate; IZ intermediate zone; MZ, marginal zone; 
SVZ, subventricular zone; VZ, ventricular zone. From Kriegstein & Álvarez-Buylla, 2009. 
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S-phase. G2 comes about while the soma is moved back to the apical wall where the cell divides 
again (Sauer 1935; Sauer & Walker 1959; Takahashi et al. 1993). NECs mainly divide symmetrically 
to amplify the neural stem cell (NSC) pool. Despite NECs are committed to neural lineage, they 
retain some features of epithelial cells, in particular their high apical-basal polarization. NECs 
are attached to the apical surface, where they form tight junctions to each other, and to the pial 
surface by integrins (Aaku-Saraste et al. 1996; Graus-Porta et al. 2001). Later in development 
NECs start to downregulate some epithelial traits and to exhibit astrocyte-typical markers in their 
transition to RGCs, coincident with the onset of neurogenesis (Kriegstein & Alvarez-Buylla 2009). 
1.1.2. Radial glia cells 
At approximately E10.5 of mouse development, with the appearance of RGCs, neurons begin 
to emerge within the cortical wall, which from a single, pseudostratified epithelium progressively 
becomes a multilayered structure. Like NECs, RGCs extend radial processes to the apical and 
basal edges –what granted their name– and undergo IKM, although tight junctions are replaced 
by adherens junctions (Martynoga et al. 2012). In addition, they share with NECs the expression 
of molecular markers as the transcription factor paired box protein 6 (Pax6), or cytoskeletal 
elements as nestin (Nes), radial cell 2 (Rc2) or vimentin (Vim), but unlike NECs, RGCs express 
some markers typical of astrocytes, such as glial fibrillary acidic protein (Gfap) or the astrocyte­
specific glutamate/aspartate transporter (Glast) (Götz et al. 2002; Osumi et al. 2008). However, 
the major difference between both cell types resides in the ability of RGCs to undergo neurogenic 
divisions in addition to their well-established role as radial scaffold (Malatesta et al. 2000; Noctor 
et al. 2001; Miyata et al. 2001). Another, perhaps most remarkable, feature of RGCs is their 
capacity to bear, though not only, three main types of cell division: symmetric non-neurogenic 
division –yielding two identical RGCs–; asymmetric non-neurogenic division –that results in a 
RGC and a mitotically active IP–; and asymmetric neurogenic division –RGC self-renews and 
arise a postmitotic newborn neuron– (Noctor et al. 2004). 
1.1.3. Intermediate progenitors 
More than a century ago it was already described a second germinal layer present in the SVZ, 
adjacent to the marginal edge of the VZ, which was eventually named basal or intermediate 
progenitor pool (Allen 1912; The Boulder Committee 1970). IPs are non-epithelial progenitors 
arisen from an asymmetrical division of a RGC in the VZ which, remarkably, do not undergo IKM. 
The newly generated cell retracts its inherited apical process, translocates its soma to the SVZ 
and exhibits a multipolar morphology in their transition to IP (Noctor et al. 2008; Borrell et al. 
2012; Wilsch-Brauninger et al. 2012). Concomitantly, IPs switch off the expression of epithelial 
progenitor-distinctive markers such as Pax6 or nestin and trigger the expression of transcription 
factors as subventricular-expressed transcript 1 (Svet1) or, more importantly, T-box brain protein 
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2 (Tbr2)/Eomes (Tarabykin et al. 2001; Englund et al. 2005). In most cases IPs bear symmetrical 
divisions; non-neurogenic –at early stages of development– to further amplify the IP pool and 
self-consuming neurogenic divisions later in development (Takahashi et al. 1995; Noctor et al. 
2004). Nowadays it is generally accepted that IPs are responsible for the genesis of most cortical 
pyramidal cells, disregarding their neuronal lineage (Kowalczyk et al. 2009; Mihalas et al. 2016). 
1.2. Spatiotemporal dynamics of neocortex formation 
The tightly regulated chain of spatiotemporal events that occurs during brain development is 
one of the most complex and fascinating biological processes ever faced, and is superbly rooted 
in the genome. 
Pallial progenitors produce specific subsets –although overlapping– of pyramidal neurons in 
an inside-out fashion, id est, newly-generated neurons migrate along previously-born ones to 
settle in the outer-more, basal zone of the prospective cortex (Figure 5). Briefly, from E10 to E12, 
cortical progenitors divide asymmetrically to self-renew and generate few neurons that undergo 
RGC-aided radial migration and form the preplate (PP). Coincidently, the Cajal-Retzius (C-R) 
cells –crucial players for cortical development and laminarization– emerge from three different 
focal sources at the borders of the developing pallium and very quickly colonize the pallial surface 
by tangentially migrating through the MZ (Marín-Padilla 1998; Soriano & Del Río 2005; Borrell 
& Marín 2006). Around E12.5, a second neurogenic wave migrates radially sitting into the PP 
–splitting it in the superficial MZ and a deep subplate (SP)– and forms the cortical plate (CP), 
which will give rise the mature, six-layered neocortex. Concomitantly, superficial to the primary 
VZ develops the SVZ, providing a secondary germinal zone that will rapidly increase the number 
Figure 5 . Spatiotemporal dynamics of 
neocortex formation . Progenitors residing in 
the VZ and SVZ produce projection neurons in 
an inside-out fashion. From approximately E10 
to E12, pallial ventricular zone (VZ) progenitors 
divide asymmetrically and generate neurons that 
migrate radially and form the preplate (PP). At 
approximately E12.5, a second wave of postmitotic 
neurons migrates radially and intercalates into the 
preplate, splitting it into the superficial marginal 
zone (MZ) and a deep subplate (SP), forming the 
cortical plate (CP), which will expand over the next 
several days and the first postnatal week into the 
mature, six-layered neocortex. The subventricular 
zone (SVZ) develops superficial to the primary VZ, 
providing a secondary germinal zone composed 
of intermediate progenitors (IPs). Over the next 
approximately 5 days, diverse cortical projection 
neuron subtypes are born in sequential and 
overlapping waves. From McDonald et al., 2013 
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of neurons, thus boosting the growth of the CP. Next, for the subsequent five days, diverse cortical 
PN subtypes are born in sequential and overlapping neurogenic waves (Figure 5). With a peak at 
E12.5, cortical PNs destined for layer VI are born, including corticothalamic PNs (CthPNs) and a 
subset of commissural/callosal PNs (CPNs). Next, peaking around E13.5, emerge an additional 
subpopulation of CPNs and subcerebral PNs (SCPNs) destined for layer V, including corticospinal 
motor neurons (CSMNs). One day later, at approximately E14.5, layer IV pyramidal neurons 
arise, including the genuine, locally projecting stellate cells. Finally, between E15.5 and E17.5, are 
generated heterogeneous subpopulations of CPN and other intracortical PNs destined for layers 
II/III (Martynoga et al. 2012; Greig et al. 2013; Huang 2014). The soon-to-be layer I (MZ) is 
occupied by C-R cells and migrating GABAergic interneurons during cortical development. In the 
mature cortex, the layer I lacks pyramidal cell somata, in contrast, it is characterized by abundant 
horizontal neurites and sparse interneurons. 
Remarkably, the cell fate advent of the cortical progenitor-derived cells during corticogenesis 
seems to follow an internal clock. Hence, NSCs first generate neurons, followed by astrocytes 
and oligodendrocytes in a sequential manner (Abney et al. 1981; Qian et al. 2000). In the mouse, 
cortical astrocytes are first detected around E16 –albeit at low numbers– and oligodendrocytes 
around birth, but the vast majority of both cell types are produced during the first postnatal month 
(Misson et al. 1991; Cameron & Rakic 1991; Rowitch & Kriegstein 2010). 
Importantly, based on previous observations from other groups (Parnavelas et al. 1991), 
the discovery by the group of John L.R. Rubenstein, twenty years ago, that cortical GABAergic 
interneurons originate outside the pallium –in the subpallial proliferative niches of the MGE and 
CGE– has revolutionized our understanding of the development of the cerebral cortex (Anderson et 
al. 1997; Marín & Rubenstein 2001). The notion that cortical pyramidal neurons and interneurons 
follow distinct developmental programs has challenged the rationale for how neurons assemble 
to constitute intricate neural networks, and still there is much to disclose (Marín & Müller 2014). 
Broadly, different subpopulations of GABAergic interneurons arise in discrete domains of the 
ventral telencephalon, in a spatiotemporally-regulated manner, from where they must tangentially 
migrate toward the developing cortex by an unprecedented long-distance migration (Anderson 
et al. 2001; Marín & Rubenstein 2001). There are three main migratory corridors followed by 
interneurons –with distinct preference by each subpopulation– to colonize the embryonic cortex: 
through the SVZ, the MZ and a slight stream through the SP (Antypa et al. 2011; Marín 2013; 
Bartolini et al. 2013). Once interneurons arrived to their corresponding cortical area, they must 
switch its tangential migratory behavior for a radial migration to invade the CP and eventually 
refine their final laminar allocation (Lopez-Bendito et al. 2008; Miyoshi & Fishell 2011; Bartolini 
et al. 2017). 
21 
   
1.3. Adult neurogenic niches 
Even though the great majority of cells within the nervous system are born during embryonic 
and early postnatal periods, new glia and neurons are continuously added in certain regions of the 
adult mammalian brain throughout life (Altman & Das 1965; Altman & Das 1967; Eriksson et al. 
1998; Frisén 2016). These newborn cells are derived from two locally-restricted niches containing 
relatively quiescent astrocyte-like NSCs: the postnatal subventricular/subependymal zone (SVZ/ 
SEZ) and the dentate gyrus subgranular zone (SGZ) of the hippocampus (Kaplan & Hinds 1977; 
Johansson et al. 1999; Kriegstein & Alvarez-Buylla 2009). In spite some fundamental differences 
between both neurogenic niches can be recognized, they share a broad structure, features and 
functioning (Alvarez-Buylla & Lim 2004). Thus, in both niches astrocytes serve as NSC pool 
(type B cell and radial astrocyte/type I progenitor in the SVZ/SEZ and SGZ, respectively) which, 
under certain signals, divide into intermediate progenitors (type C cell and type IIa/D1 cell in 
SVZ/SEZ and SGZ, respectively) which, in turn, generate newborn oligodendrocytes or neurons 
(Alvarez-Buylla et al. 2002; Vadodaria & Gage 2014; Tong & Alvarez-Buylla 2014) (Figure 6). In 
addition, a common aspect between embryonic and adult NSCs is their molecular regulatory 
network, although some key regulators exert different roles in developmental or postnatal 
neurogenesis (Urbán & Guillemot 2014). Another fundamental feature is the presence of a basal 
lamina and concomitant specialized vasculature, essential components of both niches (Palmer 
et al. 2000; Shen et al. 2008; Tavazoie et al. 2008). Furthermore, adult oligodendrogenesis has 
been extensively described, in basal conditions as well as after brain damage, with important 
implications in brain function and repair (Frisén 2016). 
Integrating intrinsic and niche-derived signals is crucial for the physiology of adult NSCs 
and there is extensive literature analyzing signals governing major processes as NSC expansion, 
quiescence maintenance or cell-fate decision (Song et al. 2012; Marqués-Torrejón et al. 2013; 
Figure 6 . Scheme of progenitor types and lineages in the adult brain SVZ/SEZ . Adult neural NSC in the wall of the 
lateral ventricles of adult rodents correspond to type B cells (SVZ astrocytes). These cells retain epithelial properties, including the 
extension of a thin apical process that ends on the ventricle and a basal process ending on blood vessels. B cells give rise to C cells, 
which correspond to neuronal IP cells (nIPCs). B cells also generate oligodendrocytes through oligodendroglial IP cells (oIPCs). From 
Kriegstein & Álvarez-Buylla, 2009. 
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 Porlan et al. 2014; Delgado et al. 2014; Urbán et al. 2016). 
In the adult mouse brain, type A cells or neuroblasts born in the SVZ/SEZ migrate extensively 
through the rostral migratory stream (RMS) to reach the olfactory bulb where they integrate into 
the network, replacing at least six different interneuron subtypes (Lois & Alvarez-Buylla 1994; 
Tong & Alvarez-Buylla 2014). As regards to the type IIb/D2-4 cells or neuroblasts of the SGZ of the 
hippocampus, although most die before integrating in the circuits, they substantially contribute 
to the granule neuron pool of the dentate gyrus (Imayoshi et al. 2008; Vadodaria & Gage 2014). 
Likewise, there are some differences in the ontogeny of these populations, while it is currently 
accepted that B cells localized at the SVZ/SEZ are derived from embryonic RGCs (Tramontin 
et al. 2003; Merkle et al. 2004), radial astrocytes or type I progenitors within the SGZ seem to 
initially originate from a population raised in the ventral hippocampus during late gestation which 
eventually relocates into the dorsal hippocampus (Li et al. 2013). 
Other remarkable difference is the evolutionarily acquired contribution of each adult neurogenic 
niche to the overall effective neurogenesis throughout vertebrates (Kempermann 2012; Bergmann 
et al. 2015). For instance, although both compartments have been shown to retain proliferative 
capacity in humans, there are robust evidences that the SVZ/SEZ is not a postnatal source of 
neurons for the human olfactory bulb (Eriksson et al. 1998; Sanai et al. 2004; Sanai et al. 2011; 
Bergmann et al. 2012). In contrast, substantial postnatal neurogenesis has been elegantly proven 
for the human hippocampus and striatum, a trait that seems almost exclusive, since only barely 
neurogenesis has been detected in the striatum of other mammals (Bergmann et al. 2015). 
The possibility to raise newborn cells on-demand constitute an exciting and unique form of 
structural plasticity whose evolutionary becoming and functional –thus clinical– implications are 
far from understood and so deserve further research (Parent et al. 2006; Imayoshi et al. 2008; 
Aimone et al. 2010; Berninger & Jessberger 2016). 
2. NEURONAL MIGRATION IN THE TELENCEPHALON 
As other organs, the CNS has managed to grow in size and complexity by using cell migration 
as a strategy to position cell types from different origins into precise –sometimes distant– areas. 
Cellular migration is a dynamic process in which, by sensing and integrating extracellular cues 
(diffuse, matrix-attached or cell-cell interactions) and intrinsic regulatory programs, the cell 
undergoes profound and locally-restricted cytoskeletal reorganizations, nucleokinesis and 
effective somal translocation that culminates with a net movement of the whole cell (Rakic 1972; 
Nguyen & Hippenmeyer 2014). 
The cytoskeleton of a neuron –actin microfilaments, intermediate filaments and microtubules– 
is the major intrinsic determinant of its shape and migration mode. Actin filaments play a central 
role in every motile intracellular rearrangement, given the large driving force provided by the 
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actin meshwork for cell movement. In addition, the other cytoskeletal systems are also fundamental 
for cell migration, for instance, microtubules are key regulators of the elongation of the leading 
process and crucial for nucleokinesis (Heng et al. 2010; Govek et al. 2011) (Figure 7). Remarkably, 
many cytoskeletal or cytoskeleton-interacting proteins are regulated at transcriptional level by 
genetic programs triggered during neurogenesis (Hand et al. 2005; Ge et al. 2006; Pacary et al. 
2011). 
Figure 7 . Importance of the cytoskeleton for neuronal 
migration . The example shows the cellular mechanisms of 
RGC-aided migration. (1) The neuron polarizes and forms 
a leading process (LP) in the direction of migration. The 
centrosome (C) is localized forward of the nucleus (N), 
which is enwrapped in a perinuclear tubulin cage (PNC). 
Microtubules (MT) extend from the centrosome into the 
leading process, and F-actin and actomyosin motors (AM) 
are enriched in the proximal portion of the leading process. 
A specialized interstitial adhesion junction (IJ) forms beneath 
the neuronal soma and punctae adherentia (PA) form beneath 
short filopodia (F) that protrude from the leading process and 
enwrap the glial fiber (GF). (2) The migration cycle involves 
forward movement of the centrosome (C) before nucleokinesis 
and soma translocation. Afterwards, the neuron takes a step 
along the glial fiber (3), a new interstitial adhesion junction 
forms and the migration cycle starts again so that migration 
continues in a cyclical, saltatory manner. From Govek et al. 
2011. 
As aforementioned, there are two main types of cellular migration in the developing 
telencephalon: radial and tangential migration. The former is characteristic of cortical PNs 
whereas the latter is typical of forebrain GABAergic interneurons. 
2.1. Radial migration of pyramidal neurons 
In 1972, pioneering work from Pasco Rakic showed that, in the fetal monkey cortex, neuronal 
somata are often juxtaposed to the radial glia fibers and hypothesized that newborn pyramidal 
neurons follow the guides offered by RGCs to reach the CP (Figure 8). Moreover, Rakic proposed 
that the entire neuron –and not only the neuronal soma, as it was previously suggested– migrates 
toward the CP, and also confirmed the inside-out pattern of radial migration, whereby later born 
neurons migrate through earlier born ones and settle into the more superficial strata of the CP 
(Angevine & Sidman 1961; Rakic 1972). 
Three different types of radial migration are distinguishable during cortical development: 
somal translocation, multipolar migration and RGC-aided locomotion (Nadarajah et al. 2001; 
Tabata & Nakajima 2003; Kriegstein & Noctor 2004). At early stages of PP/CP formation – 
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Figure 8. The process of radial glia cell-guided neuronal radial migration . (A) Camera lucida drawing of a 
Golgi-impregnated coronal section at the parieto-occipital level of the brain of a 97-day monkey fetus showing the radial fibers of 
RGCs. (B) Photomicrographs of the Golgi-impregnated telencephalon of 97 day monkey fetus showing the migrating neuronal somata 
intimately associated to radial processes. (C) Three dimensional reconstruction of the relationships between migrating cells and radial 
fibers in the intermediate zone. Adapted from Rakic, 1972. 
between E10 and E14 in the mouse– the main mode of migration is somal translocation (Miyata 
et al. 2001; Nadarajah et al. 2001). Briefly, a cell undergoing somal translocation exhibits a long 
radial process that reaches the pial surface and a short trailing process that loses ventricular 
attachment. The continuous shrinkage of the basal process and the concomitant nucleokinesis 
determine a fast migratory behavior. Somal translocation is therefore independent from non-cell 
autonomous radial fibers. In addition, this mode of radial migration is sometimes found in RGCs, 
after a neurogenic final division or in their transition to other type of RGC, as basal RGCs (Noctor 
et al. 2004; Taverna et al. 2014). On the other hand, the RGC-aided locomotion strictly relies on 
the scaffold supplied by radial processes. It is predominant at later developmental stages, from 
E14, when the thickness of the cortical wall promptly increases (Rakic 1972; Noctor et al. 2001). 
Newborn pyramidal cells undergoing radial fiber-guided locomotion present a leading process and 
a short trailing tail –which are not attached to the pial surface nor the ventricle wall, respectively– 
that seem to embrace the radial fiber during their migration (Nguyen & Hippenmeyer 2014) 
(Figure 8C). 
Last, multipolar migration is transiently observed in cells in the SVZ and deep IZ, when they 
detach from radial fibers and pause radial migration for some time. In this mode, the cell barely 
migrates and is often observed to shortly migrate tangentially, reaching a different radial process 
of that of its mother cell (Tabata & Nakajima 2003). 
2.1.1. Steps of radial migration along the cortex 
Radial migration is a multiphasic process in which neurons, as they progress from the VZ/SVZ to 
the CP, must go through rapid and striking changes in their morphology, cell polarity and migratory 
behavior (Noctor et al. 2004; Nguyen & Hippenmeyer 2014) (Figure 9). The steps of migration are 
25 
  
  
 
coordinated by extracellular cues and internal signaling mechanisms which allow the cell to form 
transient specialized structures responsible for cell polarization, protrusion, adhesion, retraction, 
etc (Heng et al. 2010). First, newborn PNs detach from the apical surface and move radially to 
the SVZ/lower IZ –where they sojourn for up to 24h– and acquire a characteristic multipolar 
morphology. During this phase, neurons actively extend and retract dynamic processes –likely 
in search of environmental cues– without a real net movement but, in some cases, retrograde 
migration toward the ventricular wall or slight tangential movements (Tabata & Nakajima 2003; 
Noctor et al. 2004). Next, neurons rapidly adopt a bipolar morphology and associate to a radial 
fiber in order to engage RGC-aided migration to traverse the IZ and invade the CP. This step is 
characterized by repetitive cycles of extension of the leading process, translocation of the nucleus, 
and retraction of the trailing process. Remarkably, this bipolar morphology and behavior crucially 
conditions cell polarity. Consequently, the axon-dendrite polarity of PNs is derived from the 
polarized emergence of the trailing and leading processes, respectively (Barnes & Polleux 2009). 
The regulatory mechanisms controlling the passage of locomoting neurons from the IZ into the 
CP, in spite they are mostly unknown, involve promigratory, instructive and permissive guidance 
cues that act as a gatekeeper for cortical PNs to enter their respective CP target zone. Ultimately, 
migrating PNs must break through the entire thickness of the CP, where they eventually detach 
from the RGC fiber and execute terminal somal translocation to conclude migration and settle in 
their appropriate position to properly integrate in the circuits (Figure 9). 
2.1.2. Molecular mechanisms underlying radial migration of pyramidal neurons 
Figure 9. Different steps of the RGC-aided radial migration and subsequent morphological changes . Cortical pyramidal 
neurons undergo distinct phases of radial migration. Phase 1  involves radial movement of pyramidal neurons (dark green) from the 
site of origin at the ventricular surface to the subventricular zone (SVZ). In phase 2, cells become multipolar and pause their migration 
in the lower intermediate zone (IZ) and subventricular zone (SVZ). Some neurons undergo phase 3, which is characterized by lateral 
translocation or retrograde motion toward the ventricle. Phase 4 represents cortical plate (CP) invasion, supported by radial glia fibers, 
in which the neurons must adopt a bipolar morpholgy. Radial glia (light green) remain mitotic, undergo interkinetic nuclear migration, 
and generate an additional daughter cell (grey). From Kriegstein & Noctor, 2004. 
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As previously introduced, neuronal migration is tightly regulated by a large panoply of intrinsic 
determinants and extrinsic signals that ultimately converge in cytoskeletal reorganizations to 
control cell locomotion, speed and direction of migration. The impact of the intrinsic burden 
of transcription factors and membrane receptor endowment on respective stages of neuronal 
migration at the mechanistic level remains largely obscure and only recently have begun to be 
deciphered (Ge et al. 2006; Ishizuka et al. 2011; Tang et al. 2014; Nguyen & Hippenmeyer 2014; 
Wiegreffe et al. 2015). In addition, it is worth noting that particular genetic programs differentially 
regulate the migration and molecular differentiation of late- and early-born cortical PNs (Lai et 
al. 2008). 
Nonetheless, extrinsic environmental cues are preeminent in controlling neuronal migration, 
although in most cases lack a mechanistic link explaining how they modulate the intrinsic 
effectors responsible for neuronal migration. The major extracellular signals modulating neuronal 
migration are the extracellular matrix (ECM), cell adhesion molecules (CAMs) and soluble or 
membrane-bound factors (Sobeih & Corfas 2002). The ECM exerts several roles, acting as a 
mechanical support, providing essential survival signals and tuning dynamics and directionality 
of neuronal migration. A noteworthy example of an ECM protein deeply affecting radial migration 
is reelin, a large extracellular glycoprotein released by C-R cells from the MZ. Reln gene is deleted 
in the reeler mutant mice and is responsible for its characteristic disrupted and inverted cortical 
layering (D’Arcangelo et al. 1995). Perturbation of any component of the reelin signaling axis 
yields a similar phenotype of that of reeler mice (Sobeih & Corfas 2002; Franco et al. 2011). In
addition, heparan sulfate proteoglycans (HSPGs) and laminins are other pivotal ECM components 
that substantially affect migration. 
CAMs are cell surface proteins that mediate cell-cell or cell-ECM interactions. The role of CAMs 
as integrins, nectins, cadherins or connexins has been shown to be crucial for RGC-dependent 
migration, as well as reelin signaling and C-R cell-dependent cortical organization (Franco et al. 
2011; Valiente et al. 2011; Solecki 2012; Gil-Sanz et al. 2013). Likewise, soluble and membrane-
bound molecules regulate many aspects of CNS development, from the initial steps of neural 
induction to the maintenance and plasticity of the adult nervous system. These factors induce 
diverse responses, including promotion of cell survival, cell-fate acquisition, cell-instructing events 
or morphogenesis. Members of the neurotrophin (NT) family –as brain-derived neurotrophic 
factor (BDNF) or NT-4– or ligands of the epidermal growth factor (EGF) receptor appear to play 
a significant role in neuronal migration (Sobeih & Corfas 2002). Additionally, guidance molecules 
–critical for axonal pathfinding– are necessary for proper radial migration of newborn PNs. For 
instance, ephrin/eph receptor forward signaling or semaphorins –acting through plexin receptors– 
modulate the activity of Rho GTPases to favor a promigratory cytoskeletal configuration (Azzarelli 
et al. 2014; Park & Lee 2015). However, the majority of extracellular promigratory or instructive 
cues profoundly influencing cortical building still remain elusive. 
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2.2. Rho GTPases in neuronal migration 
The family of Ras homolog (Rho) GTPases belongs to the large Ras superfamily of small GTP­
binding proteins. Rho GTPases are crucial regulators of cytoskeletal dynamics and affect many 
cellular processes, including cell polarity, migration, vesicle trafficking and cytokinesis (Heasman 
& Ridley 2008; Sit & Manser 2011). It comprises 20 intracellular signaling proteins well conserved 
in evolution, from plant or yeast to mammals. Most of them function by switching between 
active GTP-bound and inactive GDP-bound forms. The activity of Rho GTPases is controlled by 
three classes of molecules: guanine nucleotide-exchange factors (GEFs, facilitate the exchange 
of GDP for GTP), GTPase-activating proteins (GAPs, promote the hydrolysis of GTP into GDP) 
and guanine nucleotide-dissociation inhibitors (GDIs, sequester Rho-GDPs in the cytoplasm and 
protect them from degradation) (Boulter et al. 2010; Azzarelli et al. 2015) (Figure 10). 
Several members of this protein family play a pivotal role in neuronal migration, specifically 
by controlling microtubule stability and actin polymerization (Govek et al. 2011; Azzarelli et 
al. 2015) (Figure 10). In particular, Ras-related C3 botulinum toxin substrate 1 (Rac1) and cell 
division cycle 42 (Cdc42) modulate different phases of cortical PN migration in a cell-autonomous 
fashion (Konno et al. 2005), while Ras homolog family member A (RhoA) exerts a key non­
cell autonomous contribution to pyramidal neuron migration, since its expression is necessary 
in RGCs but dispensable in migrating neurons (Cappello et al. 2012). Moreover, RhoA gain of 
function has been shown to be detrimental for radial migration of pyramidal neurons (Tang et 
al. 2014). Hence, cell-autonomous inactivation of RhoA emerges as a critical requirement for 
cortical PN migration, and different intrinsic and extrinsic factors converge in RhoA inhibition to 
promote radial migration (Hand et al. 2005; Ge et al. 2006; Nguyen et al. 2006; Pacary et al. 2011; 
Tang et al. 2014; Azzarelli et al. 2014). Alternatively to balancing the active fraction (GTP-bound) 
of Rho GTPases, the role of proteasomal degradation has gained attention in recent years as a 
non-canonical mechanism controlling overall Rho GTPases signaling (Nethe & Hordijk 2010). 
2.3. Neuronal migration disorders 
Disruption of neuronal migration causes cortical malformations of varying degrees of severity. 
The consequences of such migration abnormalities include severe mental retardation, epilepsy 
and various intellectual disabilities (Guerrini & Parrini 2010; Barkovich et al. 2012). In some 
cases, neuronal migration is perturbed in early steps of radial migration, therefore neurons do not 
reach their correct location within the CP and form ectopic accumulations. The aberrant mass of 
neurons may remain either close to the ventricle, classified as periventricular heterotopia (PH), 
or embedded into the white matter, forming a double cortex or subcortical band heterotopia 
(SBH). In other cases, neurons are able to reach the cortical plate, but fail to properly position, 
thus giving rise to a very thick and disorganized cortex. As a consequence, the normal pattern 
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Figure 10 . The classical Rho GTPase activation cycle and main pathways regulated by active Rho GTPases . Classical 
signaling of RhoA is shown (in blue), Rac1 (in green), and Cdc42 (in purple). Guanine nucleotide-exchange factors (GEFs) activate 
Rho GTPases by promoting the release of GDP and the binding of GTP. GTPase-activating proteins (GAPs) inactivate Rho GTPases by 
increasing the intrinsic GTPase activity of Rho proteins. Guanine nucleotide-dissociation inhibitors (GDIs) sequester RhoGTPase in 
their inactive state and protect them from degradation. In their active form, Rho GTPases can bind to different effector molecules. Dia, 
diaphanous-related formins; ROCK, Rho kinase; MLCP, myosin light chain phosphatase; MLC, myosin light chain; MLCK, myosin 
light chain kinase; WAVE, Wiskott–Aldrich syndrome protein family verprolin homolog; Arp2/3, actin-related proteins 2 and 3; PAK, 
p21-activated kinases; LIMK, Lin-11, Isl-1, and Mec-3 kinase; WASP, Wiskott-Aldrich syndrome protein. From Azzarelli et al., 2015. 
of connectivity and gyrification of the brain is disrupted, leading to a simplified (pachygyria) or 
absent (agyria) degree of convolutions, typical features of lissencephaly, which owes its name to 
the smooth appearance of the brain surface (Guerrini & Parrini 2010; Barkovich et al. 2012). 
In recent years, the combination of high-resolution neuroimaging techniques and genetic 
studies brought to the identification of some genes mutated in human patients with malformations 
of cortical development (MCDs) related to migration deficits. Particularly, many disorders arise 
by mutations in genes that encode cytoskeletal proteins and their modifiers, such as tubulin alpha 
1a (TUBA1A), doublecortin (DCX), lissencephaly-1 protein (LIS-1), and filamin A (FLNA), whose 
mutations underlie severe human MCDs, including SBH, X-linked PH and lissencephaly (Guerrini 
& Parrini 2010; Barkovich et al. 2012). Accordingly, RhoA deficiency in murine RGCs dramatically 
affect radial migration and derive in double cortex formation (Cappello et al. 2012). Furthermore, 
mutations in Gpr56 –an orphan G-protein-coupled receptor (GPCR)– cause polymicrogyria, 
a severe disorder also characterized by mental retardation and seizures (Bae et al. 2014). Last, 
the most prominent group of MCDs are the focal cortical dysplasias (FCDs), in which –besides 
cortical progenitor proliferation abnormalities– neuronal migration deficits are often involved. 
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To a large extent, FCDs are caused by somatic mutations in components of the mammalian target 
of rapamycin complex 1 (mTORC1) pathway and are characterized by dysplastic neurons, cortical 
delamination and refractory epilepsy (Blümcke et al. 2011; Lim et al. 2015). 
3. POSTMITOTIC SPECIFICATION OF CORTICAL PROJECTION NEURONS 
Even though PNs represent the great majority of neurons within the cortex, the conventional 
idea was that forebrain interneurons contributed more significantly to the cellular heterogeneity 
of the cerebral cortex. However, the concept that PNs are rather homogeneous within a given 
cortical layer has been challenged lately by studies combining gene expression and target 
specificity analyses, indicating that the diversity of PN subclasses is similar to or even larger than 
that of GABAergic interneurons (Gray et al. 2004; Sorensen et al. 2015). 
In recent years, as a result of newly-developed high throughput techniques of single-cell 
transcriptome analysis, there has been an outstanding increase in the knowledge of molecular 
markers identifying specific subclasses of PNs as well as molecular mechanisms governing their 
specification, wiring and the maturation of their physiological traits (Macdonald et al. 2013; 
Molyneaux et al. 2015; Telley et al. 2015). 
As newborn neurons quit cycling, cell-specific primordial transcriptional waves dynamically 
unfold and instruct the sequence to resolve lineage-choice decisions in the cortex (Telley et al. 
2015). Today we know that many of these transcriptional regulators are coexpressed in PNs –at 
different levels depending on the prospective lineage– and strongly interact, often by reciprocally 
repressing one another (Srinivasan et al. 2012). This sets a molecular logic whereby each pyramidal 
subclass progressively refines its molecular identity and connectivity (Greig et al. 2013). 
One of the most defining features of PNs is their axonal projection pattern. This hodology-
based classification define three major groups of PNs according to whether they extend axons 
away from the cortex (corticofugal PNs), across the midline to the contralateral hemisphere 
(commissural/callosal PNs), or within one cortical hemisphere (associative PNs) (Macdonald et 
al. 2013) (Figure 11). Notably, PNs of a certain subtype located at different functional cortical 
areas (somatosensory, motor, visual or auditory) project to distinct functional targets. 
3.1. Corticofugal projection neurons 
Corticofugal PNs comprise subplate PNs (SPPNs), corticothalamic PNs (CThPNs) and subcerebral 
PNs (SCPNs), which reside in deep layers of the neocortex (V-VI) and are born sequentially early 
in corticogenesis (Figure 12). 
3.1.1. Subplate PNs 
SPPNs inhabit the deepest compartment of the layer VI and send pioneering axons to the 
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and motor areas and extend their primary axon to the spinal cord, with some secondary collaterals 
to the striatum, red nucleus, caudal pons and medulla. Further, corticotectal PNs reside in the 
visual cortex and lengthen their primary axon to the superior colliculus in the midbrain. Last, 
corticopontine PNs prolong their primary axon to targets in the pons and medulla (Macdonald et 
al. 2013). The expression of the transcription factor FEZ family zinc-finger 2 (Fezf2) is necessary 
A 
B 
Figure 11 . Major subtypes of projection neurons 
within the neocortex classified by hodology. There 
are three classes of cortical PNs: associative, commissural, 
and corticofugal. (A) Corticofugal (projections away from the 
cerebral cortex). Corticothalamic projection neurons: primarily 
located in layer VI, that project to different nuclei of the thalamus 
(purple). Subcerebral Projection Neurons: include neurons 
located in layer V and extend projections to the brainstem and 
the spinal cord. They are further subdivided into corticospinal 
motor neurons (CSMNs, light blue, located in the sensorimotor 
area of the cortex and maintain primary projections to the spinal 
cord, with some collaterals to the striatum); corticopontine PNs 
(orange) maintain primary projections to the pons; corticotectal 
PNs, located in the visual area of the cortex andmaintain primary 
projections to the superior colliculus, with secondary collateral 
projections to the rostral pons. (B) Commissural/Callosal PNs 
are primarily located in layers II/III (80%), V (20%), and VI 
(a small %) and extend axons across the corpus callosum. At 
least four major types of callosal neurons can be classified that 
maintain single projections to the contralateral cortex (red); 
dual projections to the contralateral cortex and the ipsilateral 
frontal cortex (blue); dual projections to the contralateral cortex 
and the ipsilateral caudal cortex (pink); dual projections to the 
contralateral cortex and the ipsilateral or contralateral striatum 
(green). The three last types are also considered associative PNs 
given their projections within one hemisphere. From McDonald 
et al., 2013. 
thalamus. These neurons express markers 
as complexin 3 (Cplx3), connective tissue 
growth factor (Ctgf), nuclear receptor-related 
1 (Nurr1) and monooxygenase Dbh-like 1 
(Moxd1) (Hoerder-Suabedissen et al. 2009) 
and play a pivotal role for thalamocortical 
innervation. Thereby, deviation of its 
development has been related to several 
pathologies (Hoerder-Suabedissen & Molnár 
2015). 
3.1.2. Corticothalamic PNs 
CThPNs are located primarily in layer 
VI and project to different thalamic nuclei. 
SRY-box containing gene 5 (Sox5) and T-box 
brain protein 1 (Tbr1) are important genes 
involved in their specification. Subtype-
specific expression of Tbr1 or forkhead box P2 
(Foxp2), is commonly used to mark CThPNs 
(Molyneaux et al. 2007). 
3.1.3. Subcerebral PNs 
SCPNs are nested in cortical layer V (Vb), 
present the largest somata in the cerebral 
cortex and project their axons to targets in 
the midbrain, hindbrain and spinal cord. 
SCPNs comprise several subpopulations such 
as corticospinal motor neurons (CSMNs), 
corticotectal PNs or corticopontine PNs, 
and each of these populations can be further 
divided into additional subclasses. CSMNs are 
large pyramidal neurons that reside in sensory 
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and sufficient for the generation and specification of SCPNs (Molyneaux et al. 2005; Rouaux & 
Arlotta 2012). Downstream of Fezf2, CoupTF interacting protein 2 (Ctip2)/Bcl11b has also been 
shown to be crucial for the specification of CSMNs, as mice lacking this gene fail to send axons to 
the spinal cord and show striking fasciculation aberrations (Chen et al. 2005; Arlotta et al. 2005). 
Among the most common markers used to identify SCPNs are Ctip2, carboxyl-terminal LIM 
domain-binding protein 1 (Clim1), encephalopsin or ETS-related protein 81 (Er81) (Molyneaux 
et al. 2007). 
A 
B 
Figure 12 . Neocortical projection neurons are generated in sequentially cortical progenitors in the VZ and SVZ .
The schematic depicts the sequential generation of neocortical PN subtypes and their migration to appropriate layers over the course 
of mouse embryonic development. (A) Transition of neuroepithelial cells (NEC) to radial glia cells (RGC) in the ventricular zone 
(VZ). Around E11.5, RGCs start generating intermediate progenitors (IPs), which establish the subventricular zone (SVZ) and act as 
transit-amplifying cells. Cajal-Retzius (C-R) cells primarily migrate into prospective layer I, whereas PNs are born in the neocortical 
VZ and/or SVZ and migrate along radial glial processes to reach their final laminar destinations. (B) Distinct PN subtypes are born 
in sequential waves over the course of neurogenesis. The peak birth of subplate neurons (SPN) occurs around E11.5; the peak birth of 
corticothalamic PNs (CThPN) and subcerebral projection neurons (SCPN) occurs at E12.5 and E13.5, respectively. Layer IV stellate 
cells are born around E14.5. Some callosal projection neurons (CPN) are born starting at E12.5, which are born concurrently with 
CThPN and SCPN and also migrate to deep layers. Subsequently, most CPN are born between E14.5 and E16.5, and these late-born 
CPN migrate to superficial cortical layers. Peak sizes are proportional to the approximate number of neurons of each subtype born 
on each day. By birth, after neurogenesis is complete, neural progenitors transition to a gliogenic mode, generating astrocytes and 
oligodendrocytes (not shown). Adapted from Greig et al., 2013. 
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3.2. Commissural/callosal projection neurons 
Commissural/callosal PNs (CPNs) are cells of small to medium pyramidal size and considerably 
heterogeneous attending to their birth dates and eventual laminar destinations. CPNs are 
predominantly located in layers II/III –albeit considerable numbers are also found in layer V and 
VI– and extend axons across the corpus callosum or the anterior commissure, even though several 
subtypes with distinct projection patterns can be distinguished. Currently, at least four major 
types of CPNs are classified depending on complex projections to the ipsilateral and contralateral 
striatum and to other ipsilateral cortical areas (Fame et al. 2011) (Figure 11B). 
The postmitotic specification of CPNs markedly relies on a transcriptional regulation machinery 
that operates by suppressing the SCPN program. The homeodomain-containing special AT-rich 
sequence-binding protein 2 (Satb2), emerges as a key mediator of this transcriptional repression. 
It is well-established that, together with chromatin remodeling partners like the nucleosome 
remodeling and deacetylase (NURD) complex (Britanova et al. 2008) or Ski (Baranek et al. 
2012), Satb2 binds to the Ctip2 promoter region, repressing its expression and, therefore, CSMN 
specification. In the lack of Satb2, upper layer neurons are unable to cross the midline, begin to 
express SCPN markers and extend their axons through the internal capsule (Alcamo et al. 2008). 
Other upper-layer neuron specific genes, such as POU domain, class 3, transcription factor 2 and 
3 (Pou3f2/3) and cut-like homeobox 1 and 2 (Cux1/2), also play a pivotal role in CPN specification 
and –along with Satb2– are routinely used as CPN markers (Molyneaux et al. 2009). Additionally, 
LIM homeodomain 4 (Lmo4) constitutes a useful marker of CPNs located in layer V (Arlotta et 
al. 2005). 
3.3. Associative projection neurons 
APNs are present throughout the neocortex and project axons to other areas within the same 
cortical hemisphere. APNs include short-distance intrahemispheric PNs, which extend axons 
within a single cortical column or to nearby cortical columns –such as layer IV stellate neurons– 
and long-distance intrahemispheric PNs, which extend axons to adjacent or distant cortical areas 
–such as forward and backward PNs– (Greig et al. 2013). Particularly, stellate neurons –identified 
by the expression of RAR-related orphan receptor beta (Rorβ) (Schaeren-Wiemers et al. 1997)– 
seem to play an outstanding role in brain function, since layer IV receives most thalamocortical and 
intrahemispheric afferents. Given the number of cortical areas and their potential connectivity, 
the number of APN subtypes is likely to be large, especially in more complex species, but this issue 
remains to be explored. 
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4. CANNABIS AND THE ENDOCANNABINOID SYSTEM 
The plant Cannabis sativa (commonly known as cannabis, marijuana, ganja or hemp) has been 
cultivated by humans since Neolithic times. The earliest record of hemp use is a fiber cordage found 
in the Czech Republic, dated at ca. 26980 to 24870 BP, which means between 25030 to 22920 
years old (Fleming & Clarke 1998). Around five millennia ago, in the ancient China, –in addition 
to its textile uses– cannabis was prescribed for a multitude of maladies, although “when taken 
in excess it could cause seeing devils” (Mechoulam et al. 2014). Cannabis was also extensively 
used by the Assyrians, from 2000 BC to 600 BC, who made use of its inebriating and medical 
properties. It was named either gan-zi-gun-nu (“the drug that takes away the mind”) or azzalu, 
which was apparently a drug for “depression of spirits” (Mechoulam & Parker 2011). Over the last 
millennium, most cannabis use became localized from Middle East to India –where it was called 
ganjika, in Sanskrit– and was intimately associated to their cultures and spiritual practices. After 
the French Campaign in Egypt and Syria (1798-1801) leaded by Napoleon Bonaparte, returning 
soldiers import knowledge of cannabis usage to Europe. Similarly, British physicians destined 
for India brought back to Europe both recreational and medical practices (Mechoulam & Parker 
2011). For centuries, cannabis industry was of major importance in Europe and North America, 
where most mooring and ropes –crucial for sailing– were made of hemp fibers. Therefore, our 
culture stood a long tradition of industrial, recreational and medical cannabis usage, until the 
Single Convention on Narcotic Drugs (New York, 1961) applied the same restrictions on cannabis 
that on heroin or cocaine, which made of it the most widely used illicit drug. 
Among the approximately 300000 species of vascular plants described nowadays (Christenhusz 
& Byng 2016), so far, Cannabis sativa is the only one to produce the bioactive compounds known 
as cannabinoids or phytocannabinoids. These are present in cannabis as a mixture of over 100 
closely related lipidic constituents, from which we may highlight the Δ9-tetrahydrocannabinol 
(Δ9-THC or THC) and the cannabidiol (CBD) as the most abundant and physiologically relevant 
(Mechoulam et al. 2014) (Figure 13). Both compounds –and many other cannabinoids– were 
characterized by the group of Raphael Mechoulam during the 1960’s (Mechoulam & Shvo 1963; 
Gaoni & Mechoulam 1964). 
Figure 13 . Major phyto- and 
endocannabinoids . Chemical 
structures of the plant cannabinoids 
Δ9-tetrahydrocannabinol (Δ9-THC) 
and cannabidiol (CBD) and of the 
endogenous cannabinoids anandamide 
and 2-arachidonoyl glycerol (2-AG). 
From Mechoulam & Parker, 2011. 
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However, it was not until 30 years later that the molecular substrate of THC action was first 
cloned and characterized in rat brain (Matsuda et al. 1990). Shortly after, its human (Gérard et 
al. 1991) and murine (Chakrabarti et al. 1995) orthologs were also described. The gene identified 
encodes a GPCR, which was lately named cannabinoid receptor type 1 (Cnr1 or CB1), since in 
following years a gene encoding a second –peripheral– cannabinoid receptor was also discovered 
in spleen (Munro et al. 1993) and thus named cannabinoid receptor type 2 (Cnr2 or CB2). 
Two years after the discovery of the CB1 cannabinoid receptor (CB1R), Mechoulam’s lab 
isolated and characterized an endogenous brain constituent that bound to CB1Rs. It was an 
arachidonic acid (AA) derivative named anandamide, after the Sanskrit word ananda (meaning 
bliss) and the chemical nature of the compound (Devane et al. 1992). This finding confirmed 
–as it was expected– that cannabinoid receptors (CBRs) were not evolutionarily acquired 
for binding phytocannabinoids from cannabis, but endogenous ligands (endocannabinoids), 
and simultaneously opened a new field of study on an endogenous system of transduction of 
extracellular signals, the so-called Endocannabinoid System (ECS) (Mechoulam & Parker 2011; 
Pertwee 2015). 
4.1. Main components of the Endocannabinoid System 
Overall, the ECS is composed of the CBRs, the endocannabinoids (eCBs) and the enzymes 
responsible of their metabolism (synthesis and degradation). It has been proposed the existence 
of eCB intracellular transporters as well as carrier proteins (Fowler 2013), which might belong to 
the ECS, but these remain to be confirmed and thus are not further introduced. 
4.1.1. Cannabinoid receptors 
CBRs are not restricted to mammals, not even vertebrates, since several orthologs have been 
described across deuterostomes, including protochordates as cephalochordates –amphioxus 
(Elphick 2007)– or urochordates –tunicates or sea squirts (Elphick et al. 2003)–, and echinoderms 
–sea urchins (Buznikov et al. 2010)–. For some time it was believed that cannabinoid signaling 
started in deuterostomes, given that not orthologous had been found in protostomes. However, 
recently, two putative CBRs orthologs have been described in the nematode Caenorhadbditis 
elegans –which respond to anandamide and whose functions are rescued by expression of human 
CB1 (Pastuhov et al. 2016; Oakes et al. 2017)–. This fact, along with evidence from coevolutionary 
analysis of most ECS genes orthologs in nine phylogenetically distant species (McPartland et al. 
2007), point to an early origin of the ECS in ancestral metazoans. 
More importantly, there are two canonic, well-characterized mammalian CBRs: CB1R and 
CB2R. These CBRs belong to the class A GPCRs family. Thus, they are integral membrane proteins 
with extracellular N-terminal region, followed by seven transmembrane domains with three 
extracellular and three intracellular loops that end with the C-terminal domain toward the 
35 
  
 
cytoplam. CBRs exhibit 42% amino acid sequence identity in human (Shao et al. 2016), reaching 
almost 70% in the transmembrane residues, involved in ligand binding (Munro et al. 1993). Both 
CBRs typically signal through Gαi/o heterotrimeric G proteins –which inhibit adenylyl cyclase and 
decreases cAMP levels (Howlett 1985)–; activate mitogen-activated protein kinase (MAPK) 
signaling (Howlett et al. 2004) –e.g. by protein kinase A (PKA) inhibition (Davis et al. 2003) or 
by βγ-dependent activation of PI3K (Galve-Roperh et al. 2002)–; and interact with β-arrestins 
(Jin et al. 1999) to signal and internalize. Figure 14 exemplifies the main signaling cascades 
triggered by CB1R activation. Nonetheless, CBR signaling is highly pleiotropic and deeply 
dependent on the cellular context and the nature of the ligand (Turu & Hunyady 2010). Hence, 
CBRs are also capable of signal through Gα (Howlett et al. 2010), Gαq/11 (Lauckner et al. 2005), 
transactivate tyrosine kinase receptors or regulate serine/threonine kinases (Dalton & Howlett 
2012) to list a few. Additionally, CBRs have been shown to homo- and heteromerize (Mackie 
2005; Callén et al. 2012), as well as with other GPCRs (Moreno et al. 2017) or even tyrosine kinase 
receptors (Pérez-Gómez et al. 2015), which turns largely difficult to specifically address their 
signaling cascades. Recently, the inverse agonist-bound structure of CB1R has been crystalized 
(Hua et al. 2016; Shao et al. 2016), what undoubtedly will shed light to fully understand the 
complexity and potential of CBR signaling (Figure 14). 
Figure 14 . Main signaling cascades triggered by CB1R activation and functional outcomes . Several pathways activated 
by CB1R signaling are depicted. To denote some remarkable examples, CB1Rs can inhibit voltage-dependent Ca2+ channels (VDCC) 
or activate G protein-coupled inward rectifying potassium channels (GIRKs) through βγ subunits. β-arrestins participate in CB1R 
internalization and desensitization, while GPCR-associated sorting protein 1 (GASP1) directs this receptor toward lysosomal 
degradation. The canonic activation of MAPKs (MEK, Erk1/2) by βγ subunits and inhibition of adenylate cyclase (AC) and protein 
kinase A (PKA) by Gαi/o are shown. Alternatively, CB1Rs can activate mTORC1 signaling to regulate protein translation by βγ-dependent 
recruitment of PI3K-Akt. From Keimpema et al., 2011. 
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The CB1R is the most abundant GPCR in mammalian brain (Herkenham et al. 1990), although 
it is also highly expressed throughout the body and the ontogeny (Galve-Roperh et al. 2013; 
Maccarrone et al. 2014). The capacity of THC –and other cannabinoids– to activate CB1R signaling 
is responsible for the psychoactivity of cannabis, thereby, cannabinoid compounds which not 
bind to CB1Rs lack the typical physiological effects of cannabis intoxication. In the mid 1980’s, it 
was develop an in vivo assay aimed at easily measuring the magnitude of the behavioral effects of 
cannabinoids, termed “the cannabinoid tetrad assay” (Pertwee 2006), consisting in four behavioral 
tests that allow to assess the cannabinoid-dependent hypothermia, hypokinesia, analgesia and 
catalepsy. Importantly, the pharmacokinetics and pharmacodynamics of CB1R signaling largely 
influence the overall physiological response to cannabinoids (Grotenhermen 2003) and, in turn, 
are conditioned by the nature of the ligand (Mechoulam et al. 2014); the status of glycosylation/ 
acylation/phosphorilation of the receptor (Jin et al. 1999; Daigle et al. 2008; Shim 2010; Howlett 
et al. 2010; Oddi et al. 2012); the presence of CBR-regulatory proteins as cannabinoid receptor 
interacting protein 1 a (CRIP1A) (Niehaus et al. 2007) or β-arrestins (Smith et al. 2010); and 
allosteric modulators as hemopressin (Bomar & Galande 2013) or pregnenolone (Bellocchio et 
al. 2014). All these mechanisms exert a key role in the control of the intracellular trafficking, 
desensitization, downregulation, signal transduction and constitutive activity of CB1Rs. 
Unlike CB1, CB2 is mainly expressed in the periphery, where for long time it was believed 
to be exclusive of immune cells (Miller & Stella 2008; Mechoulam & Parker 2011). However, 
CB2Rs have now been found within the brain, particularly in microglial cells and embryonic and 
adult neural progenitors, with important implications in health and disease (Palazuelos et al. 
2009; Palazuelos et al. 2012; Schmöle et al. 2015). In turn, the expression of CB2 in neuronal 
cells of the adult brain is an issue of intense debate (Atwood & Mackie 2010), although there are 
recent functional evidences that suggest that CB2Rs are present –and functional– in neuronal 
cells (Stempel et al. 2016). 
In addition to the canonical CBRs, there are other proteins targeted by eCBs at submicromolar 
concentrations, normally referred to as non-cannabinoid receptors (Pertwee et al. 2010; Pertwee 
2015). Among them, we may distinguish GPCRs (e.g. GPR55); transient receptor potential 
channels (e.g. vanilloid receptor or TRPV1); nuclear receptors (e.g. peroxisome proliferator-
activated receptors PPARs); ligand-gated ion channels (e.g. 5-HT3 receptors); and some voltage-
gated Ca2+ and K+ channels (Pertwee et al. 2010; Pertwee 2015). 
4.1.2. Cannabinoids 
Rigorously speaking, a cannabinoid is a molecule able to orthosterically bind to a CBR. Therefore, 
well-accepted cannabinoids as the CBD would fall apart of this category. Then, generally speaking, 
cannabinoids are those compounds chemically related to each other that, in most cases, affect the 
ECS directly or indirectly. There are three classes of cannabinoids, depending on their origin: 
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phytocannabinoids (those from Cannabis sativa); endocannabinoids (produced by metazoans); 
and synthetic cannabinoids (artificial derivatives not found in nature) (Figure 15). 
As phytocannabinoids, we may recognize the THC, CBD, cannabinol (CBN), Δ8-THC or 
cannabigerol (CBG), with distinct affinities for CBRs, to name a few. 
Next, the two well-established eCBs are AA derivatives, the anandamide and the 2-arachidonoyl 
glycerol (2-AG). Despite a few additional eCBs have been reported, none of them has been 
confirmed to date (Matias et al. 2006; Mechoulam et al. 2014). 2-AG was discovered shortly after 
CB2R, in seek of a peripheral eCB lipid ligand (Mechoulam et al. 1995). Remarkably, anandamide 
is a partial agonist at CB1R and CB2R –with slightly better affinity for the former– whereas 2-AG 
acts as a full agonist, with higher affinity for both CBRs than anandamide (Mechoulam et al. 
2014). 
Last, there is a plethora of synthetic cannabinoids. Engineered derivatives are aim to increase 
the affinity for CBRs, to design selective inverse agonists (antagonists), to bestow selectivity by a 
given receptor or receptor pool (e.g. central or peripheral receptor pool), to delay their metabolism, 
etc (Pertwee et al. 2010). Furthermore, although they cannot be considered proper cannabinoids, 
also have been designed allosteric modulators (Stornaiuolo et al. 2015) and drugs altering the 
functioning of the eCB-metabolizing enzymes (Blankman & Cravatt 2013). It is noteworthy to 
present some synthetic cannabinoids that appear in the Results section of this Thesis, as the HU­
210 (dual agonist with higher affinity at CB1Rs); WIN55,212-2 and CP55,940 (dual agonists); and 
SR141716 or rimonabant (selective CB1R inverse agonist) (Pertwee et al. 2010). 
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Figure 15 . Main classes of cannabinoid compounds . (A) 
Depending on their origin, 3 main classes may be distinguised: 
phytocannabinoids (with a vegetal origin) from Cannabis sativa
as THC or CBD; endocannabinoids (animal origin) as anandamide 
or 2-AG; synthetic cannabinoids (artificial origin) as CP55,940 or 
HU-210. (B) Representative curves of binding affinities of different 
cannabinoids at CB1Rs. Modified from Guzmán & Galve-Roperh, 
2009 and Katona & Freund, 2012. 
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4.1.3. Endocannabinoid metabolism 
There is a remarkable feature of the ECS that makes a difference with almost the rest of 
neurotransmitter-based systems: eCBs are synthetized on demand from lipidic moieties present 
in cellular membranes. This fact implies the constant bioavailability of the substrate and the 
permanence of metabolic enzymes in an active state. For instance, anandamide and 2-AG in 
neurons are synthetized by calcium-sensitive enzymes activated upon stimulus (e.g. membrane 
depolarization and strong Ca2+ influx), which also triggers Gq/11-coupled metabotropic glutamate 
receptors that, in turn, further activate eCB-synthetic enzymes and contribute to cannabinoid 
signaling (Katona & Freund 2008; Kano et al. 2009). The metabolism of eCBs is a complex 
process, since there are numerous enzymes participating in the synthesis and degradation of eCBs 
and, consequently, a great variety of metabolic pathways, many of which are well characterized 
nowadays (Ueda et al. 2013). 
The canonic biosynthetic pathway of 2-AG involves a diacylglicerol lipase (DAGL), of which 
two isoforms (α and β) have been described (Bisogno et al. 2003). DAGL takes DAG –e.g. from 
the breaking of phosphatidylinositol bisphosphate (PIP2) into inositol trisphosphate (IP3) and 
DAG– and releases the sn-1 acyl chain to obtain 2-AG (Ueda et al. 2013) (Figure 16A). In contrast, 
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Figure 16 . Endocannabinoid metabolism by main enzymes .
(A) 2-AG generated by hydrolysis of phosphatidylinositol 
4,5-bisphosphate by phospholipase C beta (PLCβ) followed by 
cleavage of DAG by DAGL (B) Anandamide biosynthesis begins 
with the formation of N-arachidonoyl phosphatidylethanolamine 
(NArPE) by the transfer of arachidonic acid (AA) from 
phosphatidylcholine (PC) to the primary amine of PE by a 
molecularly uncharacterized CDTA enzyme. Subsequent liberation 
of anandamide from NArPE  by NAPE-PLD. (C) Endocannabinoid 
hydrolysis to AA. In the nervous system, anandamide and 2-AG 
are degraded primarily by FAAH and MAGL, respectively. Adapted 
from Blankmann & Cravatt, 2013. 
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the typical biosynthesis of anandamide is catalyzed by the N-acylphosphatidylethanolamine­
hydrolizing phospholipase D (NAPE-PLD), which hydrolyzes NAPEs –derived from 
phosphatidylethanolamine and phosphatidylcholine– to yield anandamide and a phosphatidic 
acid (Marzo et al. 1994) (Figure 16B). 
Regarding the eCB degrading pathways, despite there are several enzymes implicated, 
mainly converge in the formation of AA, with important implications for the metabolism of 
prostaglandins and other eicosanoids (Ueda et al. 2013) (Figure 16C). Within the CNS, the main 
eCB-selective degrading enzymes are the fatty acid amide hydrolase (FAAH) (Marzo et al. 1994) 
–which hydrolizes anandamide– and the monoacylglicerol lipase (MAGL) (Dinh et al. 2002) – 
which degrades 2-AG–, but there are others –as the non-selective cyclooxygenase-2 (COX2)– 
with important biological implications (Kano et al. 2009; Muccioli 2010). 
4.2. CB1 cannabinoid receptor in the CNS 
The CB1R is broadly expressed in numerous neuronal populations throughout the CNS. It is 
mainly localized in the presynapsis, where it exerts a crucial neuromodulatory role based on the 
retrograde transmission of eCB signals. Hence, it is noteworthy pointing that, often, there is a 
discrepancy between the distribution of CB1 mRNA and protein in neuronal populations across 
brain areas, especially when those are PNs (e.g. despite medium spiny neurons highly express CB1
there is barely CB1R protein within the striatum, in contrast, the protein is mainly localized to its 
anatomical targets). 
On the one hand, CB1R protein in the murine brain is highly detected (by immunostaing or 
binding of synthetic radioactively-labeled ligands) in the olfactory bulb, hippocampus, lateral part 
of the striatum and its main target nuclei (i.e. globus pallidus, entopeduncular nucleus, substantia 
nigra pars reticulata) and cerebellar molecular layer (Kano et al. 2009) (Figure 17A-E). However, 
substantial CB1R signal is detected in other important brain areas as the cerebral cortex, septum, 
amygdala, hypothalamus, some nuclei of the brainstem and the dorsal horn of the spinal cord. 
On the other hand, regarding CB1 mRNA, two distinct patterns of CB1 expression are 
distinguished. There is a uniform labeling (resulting from CB1 expression in principal cells) 
found in the striatum, thalamus, hypothalamus, cerebellum and lower brainstem, whereas a non­
uniform signal is observed in the cerebral cortex, hippocampus and amygdala, corresponding to 
interspersed CB1 highly-expressing cells (Kano et al. 2009) (Figure 17F, G). 
Additionally, CB1Rs have also been found, at much lower levels, in astrocytes (Sánchez et al. 
1998) –where are key players of the astrocyte-dependent neuronal plasticity or tripartite synapse 
(Navarrete & Araque 2008)–; oligodendrocytes (Molina-Holgado et al. 2002); microglia (Stella 
2010); and adult neural progenitors (Jin et al. 2004; Aguado et al. 2005). 
Within the neocortex and hippocampus, CB1Rs are largely enriched in GABAergic interneurons 
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Figure 17 . Distribution of CB1 protein and mRNA in the central nervous system of adult mice . (A-D) Overall distribution 
in sagittal (A, D) and coronal (B, C) brain sections of wild-type (A-C) and CB1-knockout (CB1-KO) (D) mice immunolabeled with a 
polyclonal antibody against mouse CB1R. CB1R immunoreactivity is highest along striatal output pathways, including the substantia 
nigra pars reticulata (SNR), globus pallidus (GP), and entopeduncular nucleus (EP). High levels are also observed in the hippocampus 
(Hi), dentate gyrus (DG), and cerebral cortex, such as the primary somatosensory cortex (S1), primary motor cortex (M1), primary visual 
cortex (V1), cingulate cortex (Cg), and entorhinal cortex (Ent). High levels are also noted in the basolateral amygdaloid nucleus (BLA), 
anterior olfactory nucleus (AON), caudate putamen (CPu), ventromedial hypothalamus (VMH), and cerebellar cortex (Cb). Virtual 
lack of immunostaining in CB1-knockout (KO) mice indicates the specificity of the CB1R immunolabeling. (E) CB1R immunolabeling 
in the spinal cord. Note that striking CB1R immunoreactivity is seen in the superficial dorsal horn (DH). (F,G) Representative images 
showing CB1 in situ hybridization in a sagittal (F) or coronal (G) section of adult mouse brain. From Kano, 2009 and Allen Brain Atlas. 
–particularly, in cholecystokinin (CCK)-containing basket cells and a subset of calbindin D28K– 
whereas low but consistent and appreciable expression is detected in PNs (Marsicano & Lutz 
1999). Nevertheless, an important consideration regarding CB1R function is that the amount of 
CB1Rs not necessarily suits its overall effective signaling, as it has been shown that the efficiency 
of the coupling to G proteins differs among CB1R-expressing neuronal populations (Steindel et 
al. 2013). 
The subcellular distribution of CB1Rs in diverse and dependent on the cellular type and the 
pharmacodynamics of CB1R ligands (Thibault et al. 2013), although it is generally accepted that 
CB1Rs are localized to the plasma membrane at the presynaptic compartment (Castillo et al. 
2012; Dudok et al. 2014). Nevertheless, there are reports pointing to a CB1R pool placed at the 
postsynapsis (Maroso et al. 2016) or even at the outer mitochondrial membrane (Bénard et al. 
2012), with striking functional implications for memory consolidation (Hebert-Chatelain et al. 
2016). There is extensive literature on the molecular and cellular mechanisms controlled by the 
ECS that, despite being outstanding for brain function and animal behavior, fall apart of the main 
scope of this Thesis and therefore are not further introduced. For a glimpse of the canonical role 
of the ECS as a retrograde messenger-based neuromodulatory system, and an overview of the 
two main plastic processes –synaptic short- (STD) and long-term depression (LTD)– in which it 
is involved, see (Figure 18). For extensive review see (Katona & Freund 2008; Kano et al. 2009; 
Castillo et al. 2012). 
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Figure 18 . Schematic of the model of the ECS as 
retrograde messenger-based neuromodulatory 
ensemble and its major roles . (A) Representation 
of a glutamatergic synapse and the major events 
involved in the circuit-breaker role of CB1R. Under 
basal conditions, a single action potential (1) triggers 
the opening of voltage-gated calcium channels, and 
the resulting calcium transient evokes glutamate 
release from synaptic vesicles into the synaptic cleft 
(2). Upon presynaptic hyperactivity, such as may 
occur during epileptic seizures (3), an exceedingly 
high concentration of glutamate spills over from the 
synaptic cleft and reaches perisynaptically located 
metabotropic glutamate receptors such as mGluR5. 
This event triggers Gq/11 signaling and then PLCβ
activity (4), both of which are also located at the 
perisynaptic zone integrated into the perisynaptic 
machinery (PSM) adjacent to the postsynaptic density 
(PSD) that contains ionotropic receptors. PLCβ splits 
PIP2, and when a larger amount of DAG is produced, 
perisynaptically accumulated DAGLα, converts DAG to 
2-AG. This then travels backwards through the synapse 
(5) and mediates feedback inhibition of glutamate 
release via activation of presynaptic CB1Rs and 
subsequent closure of voltage-gated calcium channels 
(6). The whole process is tightly regulated by MAGL, 
which inactivates 2-AG by catalyzing its hydrolysis 
into AA and glycerol. (B) Simple representation of 
two plastic processes mediated by CB1Rs and its main 
molecular effectors: short- (STD) and long-term (LTD) 
synaptic depression. STD is mediated by βγ-dependent 
inhibition of VGCC while LTD requires Gαi/o-dependent 
inhibition of AC (thus PKA). Both phenomenons lead 
to decreased levels of neurotransmitter released to the 
cleft. Adapted from Castillo, 2012 and Katona, 2015. 
Similarly, there is copious evidence that the ECS controls an endless repertoire of physiological 
and behavioral manifestations. It is crucial for memory (Puighermanal et al. 2009) or cognitive 
(Puighermanal et al. 2012) and motor learning (Kishimoto & Kano 2006); extinction of aversive 
memories (Marsicano et al. 2002); tuning of stress and anxiety (Jenniches et al. 2014; Morena 
et al. 2016); protection against excitotoxicity (Marsicano et al. 2003; Monory et al. 2006; Bravo-
Ferrer et al. 2016) and neurodegeneration (Fernández-Ruiz et al. 2015); control of nociception –in 
the periphery, along with CB2R (Cravatt & Lichtman 2004)–; energy balance (Quarta et al. 2010); 
or feeding behavior (Bellocchio et al. 2010; Soria-Gómez et al. 2014), to denote a few (Figure 19). 
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Figure 19 . Some important physiological functions controlled by CB1R present in the mammalian brain . Given the 
broad distribution of CB1Rs and its largely pleiotropic signaling, there is a vast array of physiological functions regulated by CB1Rs 
present in the brain. Adapted from Flores et al., 2013. 
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4.3. The ECS in mammalian brain development 
The ECS controls embryonic development even before it begins, since it has been shown to 
regulate sperm cell motility (Agirregoitia et al. 2010) and oocyte maturation (Agirregoitia et al. 
2015). Later, anandamide plays a key role in the fertilization (Harkany et al. 2007), periimplantation 
biology (Sun & Dey 2008) and subsequent early development (Galve-Roperh et al. 2013), and 
THC has been shown to disrupt neurulation in chick (Psychoyos et al. 2008). After the first 
published evidences on the presence of CB1R during human (Mailleux & Vanderhaeghen 1992; 
Glass et al. 1997) and rat (McLaughlin & Abood 1993) development, the profuse work accomplished 
by the group of Fernández-Ruiz and Ramos in the Complutense University, substantially 
contributed to characterize the expression, distribution and functionality of many components of 
the ECS throughout mammalian brain development (Berrendero et al. 1998; Berrendero et al. 
1999; Fernandez-Ruiz et al. 2000) (Figure 20). The high levels of 2-AG (comparable to those in the 
adult brain) and the atypical CB1R protein distribution –exclusively localized to the white matter 
(WM), which lacks detectable CB1 expression– during the last days of gestation (Romero et al. 
1997), led to hypothesize a different, developmental-specific role of the ECS. In subsequent years, 
several papers came out describing strikingly diverse actions of the ECS –ranging from the control 
of neural progenitors to neuronal specification or morphogenesis– that prompt the emergence of 
a new developmental research field. For extensive review see (Harkany et al. 2007; Galve-Roperh 
et al. 2013; Maccarrone et al. 2014). 
Figure 20 . Major developmental roles of the endocannabinoid system along the ontogeny . Top panel shows temporal 
changes in available quantities of the two major endocannabinoids, 2- AG and anandamide, at the indicated developmental stages. 
Concentrations of 2-AG generally exceed those of anandamide in the developing brain. Bottom panels illustrate the major events of 
embryogenesis that are regulated by endocannabinoid signaling through CB1Rs (in orange).The actions of the endocannabinoids 
and those processes potentially affected by prenatal exposure to THC are shown. The term ‘td-eCBs’ refers to target-derived 
endocannabinoids, potentially released from putative postsynaptic target cells during axon guidance. From Harkany et al., 2007. 
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4.3.1. Role of the ECS in neural progenitor proliferation 
The first evidences of the role of the ECS in the control of neural progenitor proliferation and 
neurogenesis came up more than 10 years ago, first in in vitro systems (Rueda et al. 2002), then 
in progenitors of the adult brain in vivo (Jin et al. 2004) –where CB2Rs also play an important 
role (Goncalves et al. 2008; Palazuelos et al. 2012; Bravo-Ferrer et al. 2016)–, and afterwards in 
embryonic neural progenitors (Aguado et al. 2005). In the latter study, it is shown that neural 
progenitors have the ability to produce both anandamide and 2-AG upon stimulation, raising the 
possibility of auto- and paracrine eCB signaling in neural progenitors. 
Despite the above-mentioned functional read-outs, a precise characterization of CB1 expression 
in embryonic cortical progenitors remained elusive given its low levels of expression compared to 
postmitotic cells, and some existent methodological limitations (e.g. unspecificity of commercially 
available antibodies)(Morozov et al. 2013). Nevertheless, few years ago –taking advantage of 
newly developed genetic models– we published an exhaustive and reliable determination of CB1
expression across different compartments, proving evidence that CB1Rs are present, albeit at low 
levels, in proliferative niches of the embryonic cortex (Díaz-Alonso et al. 2014) (Figure 21A-C). 
Engagement of CB1Rs has been proven to be positively coupled to neural progenitor proliferation 
(Aguado et al. 2005; Mulder et al. 2008), in normal conditions, and after an excitotoxic insult 
(Aguado et al. 2007). Consequently, CB1 knockout mice (CB1-/-) display impaired neural progenitor 
proliferation in the embryonic VZ/SVZ (Mulder et al. 2008; Díaz-Alonso et al. 2014) as well as in 
A 
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Figure 21 . Expression and signaling pathways triggered by CB1Rs in embryonic cortical progenitors . CB1 is expressed, 
albeit at low levels, in proliferative areas of the developing mouse cortex. (A) CB1 mRNA (quantified by qPCR) in E13.5 cortical 
extracts of CB1f/f, Nex-CB1−/−, and CB1−/− embryos demonstrate a low, but signifficant, CB1 expression in cortical progenitors. (B, C) 
Representative raw and binary ISH images of the same genotypes at E14.5. Semiquantitative analysis of ISH signal shows the relative 
presence of CB1 transcripts in preeminently proliferative (VZ+SVZ) and postmitotic (IZ/CP) compartments. (D) Principal signaling 
pathways activated by CB1R engagement in neural progenitors. Activation of PI3K/Akt/mTORC1 and MAPKs or AC inhibition 
converge in the regulation of some molecular effectors (β-catenin, Pax6 or CREB) which in turn tune cortical progenitor proliferation 
and cell fate. Adapted from Díaz-Alonso et al., 2012b and Díaz-Alonso et al. , 2014. 
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the adult SVZ/SEZ and SGZ (Jin et al. 2004). In contrast FAAH deficient mice (FAAH-/-) –with 
increased eCB tone– present the opposite phenotype (Aguado et al. 2005; Mulder et al. 2008). 
The intracellular signaling cascades triggered by CB1Rs in neural progenitors are diverse (e.g. 
inhibition of PKA and activation of MAPKs or PI3K/Akt) and converge in the modulation of cell 
cycle regulators, determinants of neural progenitor’s fate or master transcriptional regulators, as 
for instance β-catenin, cAMP-response element binding (CREB) or Pax6 (Diaz-Alonso et al. 2012) 
(Figure 21D). As a remarkable example, we have described a key role of CB1Rs in the transition from 
apical (Pax6+) to basal (Tbr2+) cortical progenitors in a mechanism that involves the expression of 
Tbr2/eomes under the activation of the mTORC1/Pax6 signaling axis (Díaz-Alonso et al. 2014). 
4.3.2. Role of the ECS in neuronal migration 
The ECS, particularly the CB1R, has been involved in the regulation of the process of neuronal 
migration in different cellular contexts. Leaving apart the inconsistency of some results, the 
engagement of CB1Rs –by transactivating the TK receptor TrkB– has been shown to be positively 
coupled to the migration rate of CB1R+/CCK-containing interneurons (Berghuis et al. 2005). 
Accordingly, chronic prenatal THC administration increases the number of CCK+ interneurons in 
the dentate gyrus of the hippocampus. In contrast to these results, prenatal treatment with THC 
diminishes the number of 5-HT3A 
+/CCK+ hippocampal interneurons (Vargish et al. 2016), and 
reduces the amount of CB1R+ basket cell innervation in the CA1 pyramidal layer (Tortoriello et al. 
2014). In agreement, embryonic exposure to WIN55,212-2, seems to disrupt tangential migration 
(Saez et al. 2014), although the molecular mechanisms controlling all the above effects are still 
open questions. 
Alternatively, eCB signaling has been shown to affect the migration of SVZ/SEZ-derived 
neuroblasts toward the olfactory bulb (Oudin et al. 2011), in a mechanism that seems to involve 
PKC-dependent phosphorylation of fascin to control the actin cytoskeleton (Sonego et al. 2013). 
4.3.3. Role of the ECS in cell-fate specification 
The ECS participates in the process of cell-fate acquisition from early stages of development, 
from the above-mentioned role in the transition between cortical progenitor populations to 
promote astroglial differentiation –through the expression of astroglial markers as GFAP (Aguado 
et al. 2006) or activation of CREB (Soltys et al. 2010)– as well as neuronal differentiation and 
maturation. Remarkably, CB1 exerts a crucial role in the proper specification and maturation of 
long-range pyramidal neurons (Mulder et al. 2008), particularly, in the CSMN cell-fate acquisition 
(Díaz-Alonso et al. 2012a). In the latter study, Díaz-Alonso et al. describe a sophisticated 
mechanism whereby CB1R signaling in newborn pyramidal neurons favors Ctip2 transcriptional 
activation and proper specification of CSMNs. Accordingly, conditional knockout mice deficient 
in CB1 selectively in postmitotic cells display increased numbers of Satb2+ cells, decrease CSMNs 
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 Figure 22. CB1 cannabinoid receptor signalling and CSMN specification. CB1R activity in differentiating cortical neurons 
is coupled to the modulation of the neurogenic transcriptional factor axis Ctip2/Satb2. CB1R signaling is positively coupled to Ctip2 
transcriptional function and negatively to Satb2-mediated repression of Ctip2. Thus, CB1 tunes the transcriptional neurogenic 
programme responsible for upper and lower cortical neuron differentiation. Transcription factors involved in cortical laminar 
specification regulated by CB1 receptor are indicated in bold letters. From Díaz-Alonso et al. 2012b. 
and present evident deficits in some behavioral tests aimed at assessing the CSMN-involved 
skilled motor function (i.e. skilled reaching and staircase tests)(Díaz-Alonso et al. 2012a) (Figure 
22). 
4.3.4. Role of the ECS in neuronal morphogenesis 
The ECS affects several aspects of neuronal morphogenesis. First, activation of CB1Rs has been 
shown to trigger neurite outgrowth (Jordan et al. 2005), though it also has been reported an 
opposite effect (Berghuis et al. 2005; Vitalis et al. 2008). In particular, attending to the axon, 
CB1Rs control the specialization and molecular composition of the axon initial segment (Tapia 
et al. 2017), while results regarding axonal outgrowth are contradictory (Williams et al. 2003; 
Berghuis et al. 2005). However, it is clearer that CB1R signaling is coupled to axonal growth 
cone collapse (P. Berghuis et al. 2007; Argaw et al. 2011) with important implications for axonal 
pathfinding and final brain wiring (P. Berghuis et al. 2007). Furthermore, it has been suggested 
that eCBs may act as auto- and paracrine chemotactic cues, with an astringent spatiotemporal 
control by metabolic enzymes (Keimpema et al. 2010). In agreement, dysfunction of CB1Rs – 
either by genetic or pharmacological disruption– during development leads to remarkable 
fasciculation deficits (Mulder et al. 2008; Wu et al. 2010; Tortoriello et al. 2014), although a 
plausible involvement of CB2Rs present in oligodendrocytes has also been suggested (Alpár et al. 
2014). 
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 4.4. Prenatal exposure to cannabinoids 
Cannabis is, by far, the most widely used illicit drug among pregnant women, especially in 
Western countries. Notably, taking into consideration the lipophilic nature of cannabinoids – 
what facilitates cross-placental transfer and blood-brain barrier traversing (Hurd et al. 2005)– 
and the crucial functions endured by the ECS during embryonic development made of it an issue 
of outstanding relevance. 
The aforementioned developmental alterations caused by ECS malfunction might be 
responsible of some of the functional impairments associated to prenatal cannabinoid exposure 
(Jutras-Aswad et al. 2009; Keimpema et al. 2011; Calvigioni et al. 2014; Volkow et al. 2014). 
Additionally, it is noteworthy the ability of developmental cannabinoid administration to induce 
long-lasting –even cross-generational– epigenetic modifications (Szutorisz & Hurd 2016), which 
may be relevant for drug-seeking behaviors in the offspring (Szutorisz et al. 2016). There is 
profuse literature about the functional consequences of maternal cannabis use on the offspring, 
which include cognitive impairments (Huizink 2014) and increased susceptibility to develop 
neuropsychiatric disorders such as schizophrenia, depression or anxiety (Jutras-Aswad et al. 
2009; Mechoulam & Parker 2011; Volkow et al. 2014). Nonetheless, it is important to note that 
many human longitudinal studies present potential confounding factors (further discussed in the 
Discussion section), and that most of our knowledge on the consequences of prenatal cannabinoid 
exposure comes from animal models (Schneider 2009). Anyhow, whether embryonic cannabinoid 
administration evokes an overactivation of the ECS or, in contrast, its dysfunction, as well as the 
precise cellular and molecular substrates responsible and the long-term functional outcome of 
prenatal cannabinoid exposure remain largely understood. 
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AIMS OF THIS THESIS 
The CB1R is the most abundant GPCR in mammalian brain, with widespread distribution and 
remarkable pleiotropic actions depending on the cellular context. Previous findings from our 
group contributed to delineate a key role of CB1R signaling in the proliferation and fate-acquisition 
of cortical progenitors, as well as in the migration, CSMN specification, axonal navigation 
and morphogenesis of cortical PNs. However, the precise cellular and molecular mechanisms 
underlying the developmental role of the ECS remain to be fully explored. In addition, a precise 
characterization of the long-lasting neurobiological impact of developmental ECS malfunction 
in the adult progeny –caused by genetic variations or environmental insults such as prenatal 
marijuana exposure– is a major concern. 
In this context, we defined the following Aims for this Doctoral Thesis: 
Aim 1 . To investigate the role of the ECS in the process of radial migration of newborn pyramidal 
neurons during cortical development and to evaluate long-lasting functional alterations derived 
of developmentally-restricted CB1R dysfunction. 
Aim 2 . To elucidate the neurobiological substrate of Δ9-THC actions during embryonic 
cortical development. Particularly, to explore the impact of prenatal administration of this 
phytocannabinoid on neuronal differentiation, with special attention to CSMN specification. 
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Constructs 
pCIG2-DCX-CRE-IRES-EGFP expression vector, pCAG-DAGLα-GFP-V5 expression vector, 
pCAG-CofilinS3A expression vector and CB1 in situ hybridization (ISH) probes (sense and antisense) 
were kindly provided by Dr. Ulrich Müller (Scripps Research Institute, La Jolla, CA), Dr. Patrick 
Doherty (Wolfson Age Research Center, London, UK), Dr. François Guillemot (MRC National 
Institute for Medical Research, Mill Hill, London) and Prof. Beat Lutz (Johannes Gutemberg 
University, Mainz, Germany), respectively. 
Animals 
Experimental designs and procedures were approved by the Complutense University Animal 
Research Committee in accordance with the European Commission regulations. All efforts 
were made to minimize the number of animals and their suffering throughout the experiments.
CB1-/-, Nex-CB1-/-, Dlx5/6-CB1-/- and CB1R-rescue colony-founding mice were provided by 
Prof. Beat Lutz (Johannes Gutenberg University, Mainz, Germany). Mice were maintained in 
standard conditions, keeping littermates grouped in breeding cages, at a constant temperature
(20 ± 2 °C) on a 12 h light/dark cycle with food and water ad libitum. The generation and
genotyping of CB1-/-, Nex-CB1-/- and CB1f/f littermates has been reported elsewhere, and was 
performed accordingly (Monory et al. 2007). Mouse embryonic tissues were obtained upon timed 
mating as assessed by vaginal plug observation (E0.5). 
Rescue of CB1R expression in Stop-CB1 mice was performed as described by using Nex-Cre (Ruehle 
et al. 2013), Dlx5/6-Cre (Monory et al. 2006), and EIIa-Cre–driven recombination (Ruehle et 
al. 2013). Immunohistological characterization of different CB1R-rescue mice was performed in 
P2.5 and P20 brain samples. Corticospinal motor function as well as seizure susceptibility were 
assessed in THC- and vehicle-treated 2 month-old CB1R-rescue mice. 
THC administration 
THC (≥99% HPLC; THC Pharm) was diluted in 0.9% NaCl (saline) solution containing 3% (vol/ 
vol) DMSO and 2% (vol/vol) Tween-80 and administered intraperitoneally (i.p.) at a final dose 
of 3 mg/kg to pregnant females for 5 consecutive days, from E12.5 to E16.5. Control mice were 
injected with vehicle solution. 
Immunofluorescence and confocal microscopy 
Cell proliferation was determined after i.p. bromo-deoxyuridine (BrdU) injection (50 μg/g body 
weight) of pregnant females at E14.5. Coronal embryonic and postnatal brain slices (14 and 30 
μm-thick, respectively) were processed as previously described (Díaz-Alonso et al. 2012). Cortical 
layers were identified by their discrete cell densities as visualized by DAPI counterstaining. 
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Immunofluorescence was performed, after blockade with 5% (vol/vol) goat serum in PBS 0.25% 
(vol/vol) Triton X-100, by overnight incubation at 4°C with the indicated primary antibodies: 
anti-CB1R (1:500; Af530-1/Af380-1; Frontier Institute), anti-ER81 (1:500; ab81086; Abcam), 
anti-VGLUT1 (1:1000; 135303C3; Synaptic Systems), anti-VGAT (1:1000; 131003; Synaptic 
Systems), anti-Pax6 (1:200; ab2237; Millipore), anti-Tuj1 (1:2000; T8660; Sigma-Aldrich), anti-
Satb2 (1:200; ab51502; Abcam), anti-GFP (1:2000; 4745-1051; AbD Serotec), anti-RhoA (1:1000; 
ARH03; Cytoskeleton), anti-cleaved caspase-3 (1:500; #9661; Cell Signaling), anti-GFAP-Cy3 
(1:2000; C9205; Sigma-Aldrich), anti-Ki67 (1:1000; RM-9106; Thermo Scientific), anti-Cre 
(1:500; 69050-3; Millipore), anti-PCNA (1:1000; sc-56; Santa Cruz) and anti-BrdU (1:200; 
ab6326; Abcam). Samples were subsequently incubated for 1.5 h at room temperature with 
the appropriate highly cross-adsorbed AlexaFluor secondary antibodies (Invitrogen). Confocal 
fluorescence images were acquired by using a Leica TCS-SP2 software (Wetzlar, Germany) and SP2 
microscope with 2 passes by Kalman filter and a 1024x1024 collection box. Immunofluorescence 
of cortical sections was performed, and labeled cells were quantified in a 300 μm-wide cortical 
column of equivalent sections from the mediolateral area of the motor/somatosensory cortex. At 
least five independent cortical columns were analyzed per mice. Immunofluorescence data were 
obtained in a blinded manner. 
In CB1 knockdown experiments by in utero electroporation, cell migration was measured by 
assessing the position of GFP-positive cells along the cortical wall, assigning each cell to the 
corresponding cortical compartment attending to histological criteria defined by DAPI staining. 
RhoA immunoreactivity quantification in primary cortical culture experiments was performed 
with ImageJ software, as previously described (Díaz-Alonso et al. 2012). Targeted cells were 
identified and their contour was delimited by GFP fluorescence. The number and length of primary 
neurites was calculated with the NeuronJ plugin of ImageJ. 
In utero electroporation (IUE) 
The indicated siRNAs or expression constructs were electroporated at a final concentration of 10 μM 
or 1 μg/μl, respectively. The siRNA/DNA solution was mixed with Fast Green (0.1 mg/ml; Sigma-
Aldrich) and ~1 μl of the solution was injected into the lateral ventricle of E13.5 or E14.5 embryos 
as described previously (Borrell et al. 2005). Unless otherwise is stated, all electroporations shown 
include a constitutive GFP overexpression plasmid (pCAG-EGFP) to allow proper visualization. For 
CB1 knockdown experiments, the small interfering RNA (siRNA) SMARTpool ON-TARGETplus Cnr1
siRNA (target sequences: 5’-GGUAGUCCCUUCCAAGAAA-3’; 5’-CCACAGAAAUUCCCUCUAA-3’; 
5’-GGGAAGAUGAACAAGCUUA-3’; 5’-GUGUUUGCCUUCUGUAGUA-3’) or control 
(scrambled) siRNA (Thermo Scientific), and mouse Cnr1 short hairpin RNA (shCB1; 
5’-CTGTTAAGATCGCCAAGGTGACCATGTCT-3’) or control (scrambled) shRNA (Origene) were 
used. For CB1 ablation in CB1f/f embryos, the following Cre expression vectors were employed: 
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pCAG-CRE-GFP (Addgene) and pCIG2-DCX-CRE-IRES-EGFP (Franco et al. 2011). Additionally, 
some experiments involved the coexpression of either an shRNA directed against RhoA mRNA
(shRhoA; 5’- CAAGAAGGACCTTCGGAATGACGAGCACA-3’; Origene) or a pCAG-CofilinS3A 
construct (Pacary et al. 2011). In utero electroporated embryos were analyzed at E16.5, E17.5, P2, 
P10 or P60, as indicated. 
CSMN retrograde labeling 
Deeply anesthetized mice were injected with 0.5 μL of red fluorescent microspheres (Retrobeads; 
Lumafluor Inc.) into the dorsal funiculus of the cervical spinal cord at P10 and perfused at P15. 
Brains were sectioned coronally at 30 μm, and CSMNs in a 300 μm-wide cortical column of the 
sensorimotor and lateral sensory cortex were counted on every sixth section, across the entire 
rostrocaudal extent of the cortex, and referred to a 1 mm-wide cortical column. 
Behavioral determinations of skilled motor function 
THC or vehicle-exposed CB1−/− and CB1+/− littermates (10 week of age) were tested for skilled­
reaching and staircase tests as previously described (Díaz-Alonso et al. 2012). Control 
determinations, including the number of trials and the success ratio in unskilled conditions 
(i.e., the ability to retrieve a pellet at a tongue-reaching distance), were performed. All tests were 
video-recorded for subsequent analysis and blind quantification. Results shown correspond 
to the average of two trials for each test. Additional characterization of general motor activity 
and exploration was performed with ActiTrack (Panlab), which evidenced an absence of major 
impairments in global motor function. 
Pentylenetetrazole (PTZ)-induced seizures assay 
PTZ (Sigma-Aldrich) was dissolved in 0.9% saline and administered i.p. to mice at P60 at a 
concentration of 22.5 mg/kg (at 10 μl/g) every 10 min until generalized seizures occurred. Mice 
were placed in Plexiglas cages and injected every 10 min, by an experimenter blinded to their 
treatment and genotype, until generalized seizures occurred, what was considered the end of the 
experiment. All the procedure was video-recorded and analyzed later by an experimenter blinded 
to the experimental groups, who determined the precise moment of generalized seizure onset. 
There was no statistically significant difference in weight or sex ratio between the different groups 
of mice. 
Cortical explant migration assay 
Cortical explants were prepared from E14.5 embryonic forebrain slices prepared as previously 
described (Mulder et al. 2008). Particularly, we started from 250 µm-thick embryonic brain slices, 
from which cortical fragments of ~300 µm diameter were dissected with scalpel and incubated 
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for 1 h in Eagle’s Minimal Essential Medium (EMEM; Lonza) containing 10% FBS, 1% glucose at 
37 °C in 5% CO2. COS7 cell aggregates expressing GFP-alone, or together with pCAG-DAGLα­
GFP-V5 or pCMV-NAPE-PLD (Origene) expressing plasmids, were prepared by diluting a pellet 
of transfected cells with Matrigel (BD) in a 1:1 proportion. After jellification, cell aggregates were 
cut with a scalpel in small cubes of ~600 µm long. Subsequently, cortical explants were placed 
in a Matrigel three-dimensional matrix facing corresponding COS7-transfected cell aggregates. 
Cocultures were maintained in Neurobasal culture medium (Gibco), supplemented with N2 
(Millipore) and B-27 (Invitrogen) for 72 h, and then fixed. Cell migration from the explants 
was analyzed in 4 quadrants by quantification of cell nuclei counterstained with DAPI, and the 
proximal/distal (P/D) ratio with respect to the corresponding cell aggregate was calculated. 
In situ hybridization (ISH) 
Coronal sections (20 μm) of E16.5 and E17.5 embryonic mouse brains were obtained and processed 
for ISH as described (Marsicano & Lutz 1999). Antisense and sense Cnr1 (CB1) riboprobes were a 
kind gift from Prof. Beat Lutz (Johannes Gutenberg University, Mainz, Germany). In some cases, 
CB1 ISH was followed by immunofluorescence of GFP or Satb2 protein in the same samples. 
Binding assay of radioactively-labeled ligand 
Binding analysis was performed as described (Ruehle et al. 2013). Briefly, perinatal sections were 
incubated for 3 h at 30 °C in 50 mM Tris·HCl pH 7.4, containing 5% (wt/vol) defatted BSA and 
5 nM of the CB1R synthetic agonist [3H]CP55,940 (124 Ci/mmol; Perkin-Elmer). Nonspecific 
binding was determined by incubating adjacent sections in the presence of 10 μM cold CP55,940 
(Tocris Bioscience). After incubation, sections were washed, briefly dipped in distilled water, and 
dried overnight. Tritium-sensitive phosphor screens were exposed to slides for 3.5 d and scanned 
using a Cyclone Plus Storage Phosphor System (Perkin-Elmer). Ligand binding to CB1R was 
quantified from the standard curve compiled by using a tritium standard (American Radiolabeled 
Chemicals) and Optiquant software (Perkin-Elmer). A minimum of four sections per mice were 
quantified, and after subtraction of nonspecific labeling, the average density was calculated for 
each animal. Mean values for each condition were expressed relative to those from vehicle-treated 
animals. 
Adherent cortical progenitor cell (CPC) culture 
Primary CPC cultures were obtained from wild-type E14.5 embryos. Dorsal telencephalic tissue 
was dissected, subjected to mild enzymatic digestion with Accutase (Sigma-Aldrich), mechanically 
homogenized and grown in laminin-coated flasks containing Euromed medium (Euroclone) 
supplemented with 0.1% BSA (Sigma-Aldrich), 1% N2, laminin (2 µg/ml; Sigma-Aldrich), EGF 
and FGF (20 ng/ml; Gibco). Modulation of RhoA levels by CB1R signaling was assessed by treating 
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differentiating CPCs with the CB1R synthetic agonist HU-210 (50 nM; Tocris) with or without 
the CB1R inverse agonist SR141716 (1 μM; Sanofi-Aventis) or the proteasome inhibitor MG-132 
(10 μM; Sigma-Aldrich) for 6 hours. Differentiation was achieved by switching to Neurobasal 
medium supplemented with B-27 and N2. Adherent CPC cultures were characterized by qPCR 
and immunofluorescence analyses (Fig. S1.5). Transcript levels of CB1, nestin and RhoA were 
quantified in proliferating and differentiating conditions. Immunodetection of Pax6 and Tuj-1 
was used to assess RGC identity and postmitotic neurons, respectively. 
RhoA activity measurement 
Dorsal telencephali from E17.5 Nex-CB1−/− and CB1f/f littermates were carefully dissected and 
directly processed for active RhoA quantification with the G-LISA kit (Cytoskeleton Inc.), following 
manufacturer instructions. 
Immunoblot assays 
Embryonic cortical tissue, collected at E17.5 or P2.5, and CPC protein extracts were prepared 
in radioimmunoprecipitation assay (RIPA) lysis buffer supplemented with protease inhibitors. 
Equal amounts of protein samples were electrophoretically separated and transferred to PVDF 
membranes. After blocking with nonfat dry milk, membranes were incubated overnight at 4 °C 
with anti-CB1R (1:1000; Af380-1; Frontier Institute), anti-RhoA (1:1000; ARH03; Cytoskeleton), 
anti-RhoB (1:1000; #2098; Cell Signaling), anti-β-actin (1:5000; A5441; Sigma) or anti-α-tubulin 
(1:5000; T9026; Sigma) primary antibodies. Subsequently, membranes were incubated with 
the corresponding secondary antibodies coupled to horseradish peroxidase for 1.5 h at room 
temperature. The optical density of the relevant immunoreactive bands was quantified with the 
gel quantification plugin of ImageJ software and normalized to those of α-tubulin or β-actin for 
the corresponding samples in the same membranes. 
Quantitative PCR 
RNA was isolated using RNeasy Plus kit (Quiagen). cDNA was obtained with Transcriptor 
(Roche). Real-time quantitative PCR (qPCR) assays were performed using the FastStart Master 
Mix with Rox (Roche) and probes were obtained from the Universal Probe Library Set (Roche). 
Amplifications were run in a 7900 HT-Fast Real-Time PCR System (Applied Biosystems). Each 
value was adjusted by using 18S RNA and β-actin levels as reference. 
Statistical analysis 
All variables were first tested for normality (Kolmogorov–Smirnov) and homoscedasticity 
(Levene’s). When variables satisfied these conditions, one-way ANOVA and LSD Fisher post hoc
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tests were used to assess differences between groups.  In other cases, the differences were analyzed 
by nonparametric (Kruskal–Wallis) tests, and post hoc comparisons by means of Mann–Whitney 
Wilcoxon test were used to assess differences between groups. Significance level was set below 
0.05 in all cases. Results are shown as mean ± SEM, and the number of experiments is indicated 
in every case. All analyses were carried out using Statgraphics Centurion XVII software (Statpoint 
Technologies Inc.). 
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AIM 1: SUMMARY 
Proper radial migration of PNs is essential as it establishes the basis for the subsequent wiring 
of the cortical circuitry. Not surprisingly, a wide spectrum of brain abnormalities emerge as a 
consequence of disrupted neuronal migration, which can have devastating consequences on adult 
brain function, including mental retardation, cognitive disorders and epilepsy. 
The CB1R is expressed in the developing cerebral cortex, where it controls the proliferation 
and phenotype of cortical neural precursor cells (Díaz-Alonso et al. 2014), the specification of 
pyramidal neurons (Díaz-Alonso et al. 2012), and axon guidance and synaptogenesis (Mulder 
et al. 2008; Vitalis et al. 2008; Keimpema et al. 2010; Argaw et al. 2011). In addition, the CB1R 
regulates neuronal migration in the embryonic brain (Mulder et al. 2008), and eCB signaling 
promotes migration of newborn neurons along the RMS in the postnatal mouse brain (Oudin et 
al. 2011). Deciphering how CB1Rs signal in the developing brain is critical for understanding the 
neurobiological processes affected by developmental CB1R malfunctioning. 
In this study, we performed transient siRNA-mediated CB1 knockdown in newborn pyramidal 
neurons to reveal the impact of developmentally restricted, short-term CB1 loss of function on 
radial migration and potential functional deficits in adulthood. We observed a migration arrest 
that led to profound and long-lasting alterations in cortical neuron positioning, the formation of 
neuronal heterotopias and increased seizure susceptibility in adult mice. Biochemical and cellular 
analyses showed that loss of CB1R function led to abnormal RhoA accumulation in newborn 
pyramidal neurons, thereby disrupting the morphology of migrating cells. Remarkably, migration 
deficits elicited by CB1R dysfunction were fully rescued by RhoA knockdown. Collectively, our 
findings pave the way toward a better understanding of the physiological role of the ECS in brain 
development, and provide relevant molecular mechanistic insights into human MCDs caused by 
altered neuronal migration. 
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AIM1. ROLE OF THE ECS ON PYRAMIDAL NEURON RADIAL MIGRATION AND 
LONG-LASTING CONSEQUENCES OF DEVELOPMENTAL CB1R DYSFUNCTION 
R1.1. Acute CB1 knockdown blocks radial migration 
To evaluate the role of CB1 in neuronal migration we initially confirmed its expression in the 
developing cortex at E17.5. Both CB1R mRNA and protein show a gradient with increased levels 
in postmitotic compartments of the developing cortex, i.e. the IZ and the CP (Fig. R1.1A-C), 
suggesting that CB1 expression is upregulated in newborn pyramidal neurons after cell cycle exit 
and radial migration initiation (Díaz-Alonso et al. 2014). We also explored the presence of CB1Rs 
in developing pyramidal neurons by combining CB1 ISH with Satb2 immunofluorescence (Fig. 
R1.1A, right panel). Confocal analysis further confirmed CB1R protein expression in immature 
Satb2+ pyramidal neurons in E17.5 embryonic cortices, a large proportion of which are undergoing 
radial migration at this developmental stage (Fig. R1.1C). In brain development, CB1R protein is 
enriched in axons of immature PNs (Fig. R1.1C) (Berrendero et al. 1999; Mulder et al. 2008), 
making extremely difficult to estimate the contribution of somatic CB1R immunostaining in 
migrating neurons to the overall staining. Thus, to recapitulate CB1 expression in migrating 
pyramidal neurons, we used ISH of CB1 transcripts in GFP-positive cells in E16.5 embryonic 
cortices subjected to IUE at E14.5 (Fig. R1.1B). As developing GABAergic interneurons also express 
CB1Rs (Paul Berghuis et al. 2007; Morozov et al. 2009), to unequivocally assess the presence 
of CB1Rs in pyramidal neurons we took advantage of the Dlx5/6-driven forebrain GABAergic 
neuron-selective CB1-deficient mice (Monory et al. 2007). Thus, in Dlx5/6-CB1-/- embryonic 
cortices, CB1R immunostaining was hardly distinguishable from their CB1f/f littermates, while in 
the developing hippocampus a clear reduction of CB1Rs was evident (Fig. R1.1D). Overall, these 
results confirm the expression of CB1 in radially migrating pyramidal neurons, in addition to its 
presence in developing interneurons. 
We then assessed the cell-autonomous role of CB1R signaling in PN migration during cortical 
development. To this end, we acutely knocked-down CB1 in radially-migrating neurons at 
E14.5 by IUE of a pool of siRNAs directed against 4 sequences of CB1 mRNA (hereafter siCB1) 
together with a GFP expression construct, and subsequently analyzed the distribution of radially­
migrating cells at different time points. In our hands, transfection of cortical cells with this siRNA 
pool reduces CB1 expression below 40% (Díaz-Alonso et al. 2014). CB1 knockdown significantly 
impaired newborn pyramidal cell migration (Fig. R1.2A-C). Remarkably, after either 2 or 3 DIU
(Fig. S1.1A, B and Fig. R1.2A,B, respectively), we observed a reduced colonization of the CP by 
CB1-deficient cells that, instead, appeared stacked in the IZ and the VZ/SVZ. Moreover, when 
we restricted our analyses to the intracortical migration (i.e. cells within the CP), we also found a 
significant delay in siCB1-electroporated cells, that were less abundant in upper cortical layers of 
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Figure R1.1. Detailed characterization of CB1 expression in 
migrating pyramidal neurons. (A) In situ hybridization (ISH) of 
CB1 transcripts in the developing cerebral cortex at E17.5. Antisense and 
sense probes were employed to confirm the specificity of the detection. 
Insets show higher magnification images of the intermediate zone (IZ) 
where migrating neurons are crossing to reach the cortical plate. The 
presence of the CB1 transcripts in pyramidal neurons was analyzed by 
ISH as above, followed by Satb2 immunofluorescence. Inset shows 
high magnification image of a representative migrating neuron in the 
IZ. (B) CB1 transcripts were revealed by ISH in E16.5 cortices subjected 
to IUE with a GFP expression plasmid at E14.5 to visualize migrating 
pyramidal neurons. (B’-B’’’) high magnification details of CB1 mRNA
expression in GFP+ pyramidal neurons en route to their destination in 
the CP. Arrows point to GFP-labeled migrating pyramidal neurons. (C) 
Double immunofluorescence using antibodies for CB1R and the upper 
layer marker Satb2 was performed in E17.5 sections. Representative 
high magnification insets of the IZ and CP are shown. CB1+/Satb2+ 
coexpressing cells are indicated by arrows (IZ) and arrowheads (CP). 
(D) CB1R immunofluorescence in CB1f/f and Dlx5/6-CB1-/- littermates 
revealing a similar CB1R expression pattern, and thus confirming the 
pyramidal identity of CB1R expressing neurons. High magnification 
images are shown in middle panels (Z-stack projection). As a control of 
CB1 conditional deletion, CB1R immunoreactivity in the hippocampus 
was clearly reduced in Dlx5/6-Cre+ embryos. Scale bars: A, 100 μm; 
inset 10 μm; B, 50 μm; B’-B’’’, 10 μm. C,D, 100 μm; inset 20 μm 
the cortex, where E14.5-born neurons are committed to migrate (Greig et al. 2013) (Fig. R1.2C). We 
confirmed that acute CB1 silencing impairs radial migration by using additional strategies: both a 
CB1-directed short-hairpin RNA (CB1 shRNA, not shown) and Cre recombinase electroporation 
in CB1f/f embryos (Fig. S1.1C,D) perturbed migration of cortical projection neurons at very similar 
extent than siRNA-mediated CB1 knockdown. 
To invade the CP, migrating neurons must undergo a morphological switch from their 
characteristic multipolar shape, adopted to explore the SVZ and IZ environment, to a bipolar 
morphology, which enables their RGC-aided migration into the CP (Heng et al. 2008; Pacary et al. 
2011). Acute CB1 knockdown increased the number of primary neurites in cultured E14.5 cortical 
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neurons (Fig. S1.1E-G). Hence, we analyzed whether silencing of CB1 affects the morphology of 
migrating neurons in vivo. We quantified the number of GFP+ cells with more than 2 primary 
processes in the CP of control siRNA and siCB1-transfected brains, and found a 2-fold increase 
in the proportion of cells with this aberrant morphology in siCB1-electroporated cortices 
(Fig. R1.2D,E), thereby indicating that radial migration blockade occurs concurrently with an 
Figure R1.2. Cannabinoid CB1 knockdown impairs pyramidal neuron migration . (A-C) Analysis of the migration of 
cortical neurons electroporated in utero with CB1 siRNA or a control siRNA together with a GFP expression plasmid at E14.5 and 
analyzed 3 days later, at E17.5. Representative images are shown (A). The distribution of GFP+ cells in the ventricular/subventricular 
zone (VZ/SVZ), intermediate zone (IZ) and CP of the developing cerebral cortex in both conditions was quantified (B). The migration 
of targeted cells within the CP (uCP, upper CP; mCP, median CP; lCP, lower CP) was also analyzed (C). (D,E) The morphology of CP 
migrating cells was analyzed, and we quantified the proportion of cells with more than 2 primary processes. Arrows point to abnormal 
primary processes in CB1-knockdown cells. n= at least 3 different embryos from different litters per condition. Graphs represent mean 
± SEM. *P < 0.05; **P < 0.01; ***P < 0.001. Scale bars: A, 100 μm; D: 10 μm. 
impairment of the multipolar to bipolar transition. 
R1.2. Transient CB1 knockdown long-lastingly perturbs neuronal migration and 
generates SBH 
To assess whether CB1-deficient cells suffer from a transient delay in their radial migration 
but finally reach their appropriate cortical layer if given enough time, as is the case following 
the silencing of other important regulators of cell migration (Creppe et al. 2009; Manent et al. 
2009), we extended our E14.5 IUE experiments until early postnatal life (P2 and P10), when the 
siRNA is no longer active. In P2 brains, the migration arrest observed upon CB1R downregulation 
was still present (Fig. R1.3A,B), thus confirming that temporally restricted CB1 loss of function 
compromises radial migration of newborn neurons in the developing cortex. In P10 brains we 
observed a larger proportion of GFP+ cells in the upper layers of siCB1-electroporated cortices, 
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although we consistently found GFP+ cells in deep cortical layers, and extraordinarily, we also 
observed accumulations of GFP+ cells stacked into the WM (Fig. R1.3C,D). Furthermore, siRNA­
electroporated mice that develop until young adults (P60) were assessed for the definitive 
positioning of transfected cells. Strikingly, we consistently found subcortical accumulations of 
GFP+ neurons in the majority of siCB1-electroporated brains (Fig. R1.3G-I). 
Figure R1.3. Transient CB1 knockdown generates long-lasting aberrant neuronal positioning and subcortical band 
heterotopia (SBH) . (A,B) Migration analysis of cortical neurons electroporated in utero with siCB1 or a control siRNA together 
with a GFP expression plasmid at E14.5 and analyzed at P2. Electroporated cell distribution was analyzed in the indicated cortical 
layers and white matter (WM). (C,D) Brains electroporated at E14.5 were analyzed as above at P10. (E,F) Migration-arrested GFP+ 
cells from electroporated P10 brains were stained with the callosal projection neuron marker Satb2. The specification of targeted cells 
was quantified in control and siCB1 electroporated cortices (F). (G) Subcortical accumulations of pyramidal neurons were evident in 
siCB1-electroporated brains at P60. (G’, G’’) detail of the expression of the callosal projection neuron marker Satb2 in subcortical 
heterotopias (SBH). Arrows point to Satb2+/GFP+ cells. (H) The SBH nature of the lesions was confirmed by the identification of a 
glial GFAP-immunoreactive capsule around the ectopic cell accumulations. (I) Example of a SBH-like lesion in another P60 siCB1­
electroporated brain. n= at least 3 different embryos from different litters per condition. Graphs represent mean ± SEM. *P < 0.05; 
**P < 0.01. Scale bars: A, E, 100μm (insets, 20 μm); C, 200 μm; G’, H, 200 μm; G’’, 25 μm; I, 100 μm. 
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We next determined the identity of GFP+ CB1-knocked-down cells at postnatal stages. Cells found 
in deep cortical layers of siCB1-transfected brains at P10 were immunoreactive for the callosal PN 
specification marker Satb2 (Alcamo et al. 2008) (Fig. R1.3E,F). Additionally, we found that the 
vast majority of GFP+ cells within the subcortical heterotopias at P60 were also immunopositive 
for Satb2 (Fig. R1.3G-G’’), even though the expression of this transcriptional regulator in the 
telencephalon is normally confined to the cerebral cortex (Alcamo et al. 2008). This observation 
indicates that arrested cells retain their corresponding callosal specification program even in 
ectopic locations. We then asked about the nature of the ectopic neuronal accumulations present 
in siCB1-transfected brains. SBH can be distinguished from PH because neuronal accumulations 
are surrounded by a glial capsule in SBH but not in PH. Hence, we stained samples from siCB1­
electroporated P60 brains for the astrocytic marker GFAP and confirmed that the neuronal 
accumulations correspond to the SBH type (Fig. R1.3H). 
We then explored whether the observed CB1R-dependent promotion of radial migration was an 
exclusive mechanism of E14.5-born cells. To this end, we performed IUE at E13.5 and conducted 
analyses 3 days later (Fig. S1.1H-I). Similarly to our previous manipulations at E14.5, when 
targeting E13.5-born PNs an overall delay in GFP+ cell migration was observed in CB1-knocked­
down brains after 3 DIU. Likewise, perturbed radial migration was still evident at P2 in CB1f/f mice 
electroporated at E13.5 with a Cre-expressing vector (Fig. S1.1C,D). 
R1.3. CB1Rs present in postmitotic pyramidal neurons promote radial migration 
CB1 plays an active role in the regulation of cortical progenitor cell proliferation and identity 
(Mulder et al. 2008; Díaz-Alonso et al. 2014). Hence, we determined whether the observed 
CB1-dependent promotion of pyramidal neuron migration involves CB1Rs located on cortical 
progenitor cells. To test this possibility, we electroporated a Cre-encoding construct driven by the 
postmitotic neuron-specific promoter Dcx (Fig. S1.2) (Franco et al. 2011) in E14.5 CB1f/f embryos, 
and analyzed the position of targeted cells at E17.5 (Fig. R1.4A-C). A clear migration defect was 
evident upon CB1 ablation exclusively in postmitotic neurons. Importantly, this manipulation 
also affected the morphology of migrating GFP+ cells (Fig. R1.4D,E). Moreover, we tested whether 
postmitotic CB1 removal results in a transient or permanent migration impairment by allowing 
the electroporated embryos to develop until P2. Although many of the electroporated cells were 
found in the upper cortical layers at this stage, we consistently found accumulations of neurons 
ectopically located in the WM (Fig. R1.4F). These observations demonstrate that CB1R signaling 
cell-autonomously promotes radial migration in postmitotic neurons independently of the cortical 
progenitor cell pool. 
We sought for additional support to the postmitotic nature of the CB1R promigratory role by 
analyzing the migration of postmitotic neurons in CB1-/- embryos. CB1 constitutive deletion has 
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 been shown to affect several aspects of PN development (Mulder et al. 2008), although its precise 
impact on radial migration remains unclear. Thus, we performed birthdate labeling experiments 
in CB1-knockout embryos and control littermates by administering BrdU at E14.5 followed by 
double immunofluorescence for BrdU and Ki67 at E16.5, in order to recognize cells that were 
still proliferating. BrdU+Ki67- cells −i.e. the cells that had exited cell cycle between E14.5 and 
E16.5− were significantly delayed in their radial migration in CB1-/- embryos when compared to 
WT littermates (Fig. S1.3A,B). 
As the CB1R is known to trigger prosurvival mechanisms in neurons (Galve-Roperh et al. 2008), 
we assessed whether its knockdown interferes with neuronal migration by affecting cell viability. 
Hence, we analyzed the apoptosis marker cleaved caspase-3 in cortices subjected to IUE with the 
siRNAs. We did not find significant differences in apoptotic cells in the developing cortex of siCB1­
electroporated and control siRNA-electroporated cortices (Fig. S1.3C). Moreover, no differences 
were observed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining 
in siCB1-electroporated versus control cortices (Fig. S1.3D). Thus ruling out a contribution of 
neuronal survival in the promigratory effect exerted by CB1Rs. 
Figure R1 .4 . CB1R signaling promotes radial migration postmitotically . (A-C) Migration of cortical neurons was analyzed 
in E17.5 CB1f/f embryos electroporated in utero at E14.5 with a Dcx-Cre expression vector, to ablate the CB1R in postmitotic neurons, 
or Gfp as a control (see Materials and Methods section). The distribution of GFP+ cells along the developing cerebral cortex in E17.5 
is indicated in (B). Quantification of the migration of targeted cells within the CP is shown (C). (D, E) The morphology of migrating 
cells was analyzed in the CP, and the proportion of cells with more than 2 processes was quantified. Arrows point to abnormal primary 
processes in CB1-deficient cells. (F) Migration analysis of cortical neurons electroporated in utero with Dcx-Cre or Gfp at E14.5 and 
analyzed at P2. In Dcx-Cre-electroporated cortices, heterotopic GFP+ cells accumulations were consistently found in subcortical areas 
(asterisk). n= at least 3 different embryos from different litters per condition. Graphs represent mean ± SEM. Scale bars: A, F, 100 
μm; D, 10 μm. *P < 0.05; **P < 0.01; ***P < 0.001. 
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R1.4. The eCBs 2-AG and anandamide act as chemoattractant cues for newborn PNs 
Given that developmental DAGLα-dependent intercellular eCB-signaling has been suggested 
(Keimpema et al. 2013), to better understand the mechanism of CB1R-driven neuronal migration, 
we investigated the ability of the eCBs to modulate pyramidal neuron migration. We prepared E14.5 
cortical explants and exposed them to a confined source of eCBs. DAGLα is the key enzyme involved 
in 2-AG synthesis, and mice lacking this enzyme show impaired eCB-mediated neuromodulation 
and compromised adult neurogenesis. Neurons arising from cortical explants showed a marked 
preference to migrate toward DAGLα-overexpressing COS7 cells when compared with control, 
GFP-transfected cells (Fig. R1.5A,B). Alternatively, anandamide biosynthesis is mainly achieved 
through the action of NAPE-PLD. Likewise, the migration of neurons from cortical explants 
was favored towards heterologous COS7 cells overexpressing NAPE-PLD. Importantly, the 
promigratory effect of 2-AG and anandamide was blocked by coincubation with the CB1R inverse 
agonist SR141716. Thus, both eCBs promote pyramidal neuron migration by engaging CB1Rs. 
The aforementioned observations could reflect two different mechanisms: eCBs might promote 
neuronal motility and/or instruct the directionality of neuronal migration. To dissect these two 
processes we overexpressed DAGLα in utero −normally upregulated exclusively in the CP− at E14.5 
to disrupt the gradient of 2-AG, and analyzed neuronal migration at E17.5. DAGLα-overexpressing 
migrating neurons showed a mild −yet significant− delay compared to GFP-electroporated cells, 
suggesting that blurring the cortical 2-AG gradient misleads neuronal migration (Fig. R1.5B). We 
then evaluated the consequences of disturbing the cortical gradient of 2-AG on the subsequent 
waves of migrating neurons. Hence, we injected BrdU 12h after the IUE to label proliferating 
cells, and then tracked their migration at E17.5. BrdU-labelled cells accumulated aberrantly in 
the VZ of DAGLα-electroporated brains, where DAGLα-overexpressing cells were most abundant 
(Fig. R1.5C-E), thus indicating that abnormally high levels of 2-AG in the apical side of the cortex 
prevent proper PN radial migration. These findings suggest that eCBs may act as instructive, 
spatially regulated cues for the adequate migration of pyramidal neurons in the developing cortex. 
R1.5. CB1R signaling promotes RhoA degradation in migrating pyramidal neurons 
Several signaling pathways involved in the regulation of neuronal migration converge in the 
modulation of the activity of the small GTPase protein RhoA (Cappello et al. 2012; Pacary et 
al. 2013; Azzarelli et al. 2014). Given the morphological alterations found in CB1-deficient 
migrating cells, and the previous evidence suggesting a functional link between CB1R signaling 
and RhoA activity in both neuronal (Paul Berghuis et al. 2007) and non-neural (Nithipatikom 
et al. 2012; Mai et al. 2015) cells, we hypothesized that the promigratory effect of the CB1R in 
newborn pyramidal cells could rely on the modulation of actin cytoskeleton through RhoA. To 
investigate whether CB1R signaling regulates RhoA activity in vivo, we measured the amount 
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Figure R1.5. The endocannabinoids 2-AG and AEA act as promigratory cues for newborn cortical neurons . (A) 
Representative images of pyramidal neuronal migration assays from E14.5 cortical explants in response to Daglα-, Nape-pld- or 
mock (Gfp)- transfected COS7 cells. (B) The promigratory action of eCBs was quantified by determining the ratio of neurons in the 
proximal and distal (P/D) quadrants. The involvement of CB1Rs was determined by including in the medium the CB1R inverse agonist 
SR141716 (SR, 10 μM or vehicle. n= 3 independent experiments with at least 5 explants per condition. (C-E) Migration analysis 
of cortical neurons electroporated in utero with Daglα together with a Gfp expression or a control Gfp-only plasmid at E14.5 and 
analyzed at E17.5. BrdU was injected 12 h after IUE to label the subsequent wave of migrating cells. Representative images are shown. 
Quantification of GFP+ cell distribution in the indicated cortical compartments is shown (D). Analysis of BrdU-labeled cells at E17.5 
(E). n= at least 3 different embryos from different litters per condition. Graphs represent mean ± SEM. *P < 0.05; **P < 0.01. ***P < 
0.001 vs Gfp/Vehicle-treated explants of Gfp electroporated embryos; #P < 0.05; ###P < 0.001 vs the corresponding vehicle-treated 
explants. Scale bars: A, 100 μm; inset 500 μm; C, 100 μm. 
of GTP-bound RhoA in cortical tissue extracts from E17.5 embryos, when a large proportion of 
neurons are undergoing radial migration. We employed a dorsal telencephalic glutamatergic 
neuron-specific CB1 conditional knockout (Nex-CB1-/-) to determine the regulation of RhoA 
activity by CB1R signaling specifically in postmitotic cortical pyramidal neurons. We found that 
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Figure R1.6. CB1R signaling controls 
RhoA protein levels in pyramidal 
neurons . (A) Analysis of RhoA activity 
levels in CB1f/f and Nex-CB1-/- E17.5 
embryonic cortices. (B) RhoA protein 
levels were determined by Western blot 
in cortical tissue in E17.5 Nex-CB1-/- and 
CB1f/f littermates. Loading control was 
performed with anti α-tubulin antibody.
(C, D) Analysis of RhoA levels in E14.5 
primary cortical neurons electroporated 
with a siCB1 or a control siRNA and 
maintained in differentiating conditions for 
4 DIV. Mean RhoA immunoreactivity (IR) 
fluorescence intensity was calculated in the 
GFP+ area. Arrows point to RhoA-enriched 
processes in CB1-knockdown cells. n=3 
independent experiments with at least 
100 GFP+ cells from 6 imaging fields 
per experiment. (E) RhoA protein levels 
were determined by Western blot upon 
pharmacological manipulation with 
HU-210 (50 nM) for 6h in primary 
differentiating CPCs. In addition, CPCs 
were incubated in the presence of the CB1R 
receptor inverse agonist SR141716 (1 μM 
and with the proteasome inhibitor MG-132 
(10 μM). (F) RhoA protein levels were 
determined by Western blot in cortical 
samples from E17.5 embryos exposed to the 
CB1R agonist WIN 55,212-2 (5 mg/Kg) or 
its vehicle for 6 hours. n= at least 3 different 
embryos per genotype or treatment. Graphs 
represent mean ± SEM. *P < 0.05; **P < 
0.01; #P < 0.05 vs HU-210-treated cells. 
Scale bar: 25 μm. 
active RhoA levels were increased by 2-fold in E17.5 Nex-CB1-/- cortices compared to their CB1f/f 
littermates (Fig. R1.6A), suggesting that CB1R signaling dampens RhoA activity in migrating 
pyramidal neurons. This observation indicates that in Nex-CB1-/- cortical tissue either the active 
fraction of RhoA is increased and/or there is an accumulation of total RhoA protein. Hence, we 
examined total RhoA protein levels by Western blot and also found a 2-fold increase in Nex­
CB1-/- tissue extracts compared with their CB1f/f littermates (Fig. R1.6B), thus indicating that CB1
inactivation in postmitotic pyramidal neurons leads to an accumulation of RhoA protein rather 
than to an increase in the active fraction of RhoA. Subsequently, we analyzed RhoA expression in 
those samples by qPCR and found no significant differences (Fig. S1.4A), suggesting that CB1R 
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signaling likely controls RhoA at a posttranslational level rather than regulating its transcription. 
The mRNA expression levels of other Rho-family members involved in neuronal migration, RhoB, 
Rac1 and Cdc42, were neither affected by CB1 ablation (Fig. S1.4A). 
To determine whether our acute CB1 knockdown strategy also modifies RhoA protein levels, 
we performed ex vivo electroporation of siCB1 or control siRNA together with GFP into E14.5 
mouse embryonic dorsal telencephalon, and maintained dissociated cortical cells for 4 DIV. 
In agreement with Nex-CB1-/- cortical tissue, RhoA immunoreactivity was increased in siCB1­
transfected compared to control-siRNA-transfected GFP+ cells (Figure R1.6C,D). 
It has been recently reported that RhoA expression in pyramidal neurons is largely dispensable 
for their migration, and that its overactivation results in radial migration arrest (Pacary et al. 2011; 
Cappello et al. 2012). This is consistent with the expression pattern of RhoA in the developing 
cortex, which shows a clear downregulation of RhoA in migrating neurons compared to cortical 
progenitors (Azzarelli et al. 2015). Therefore, we designed an experimental approach aimed at 
recapitulating the cellular context of migrating pyramidal neurons to study how CB1R signaling 
affects RhoA levels at a mechanistic level. Thus, we obtained adherent cortical progenitor cell 
(CPC) cultures, which can be differentiated into cortical neurons by changing the medium and 
withdrawing growth factors (see Materials and Methods). Characterization of CPC cultures (Fig. 
S1.5A-E) revealed their appropriateness to model the cellular context of a migrating cortical neuron. 
As expected, neuronal differentiation reduced nestin and Pax6 expression, while increasing the 
expression of the postmitotic neuron-enriched Tuj1 and CB1. RhoA expression also decreased 
with differentiation, mirroring the abrupt downregulation that occurs during pyramidal neuron 
maturation in vivo. To evaluate whether CB1R manipulation during this process affects RhoA 
protein levels, we stimulated CB1R signaling in differentiating CPCs with the synthetic cannabinoid 
agonist HU-210 and observed that CB1R activation led to a decrease of total RhoA protein levels 
compared with vehicle-treated CPCs (Figure R1.6E). Noteworthy, HU-210-induced reduction of 
RhoA levels was prevented by SR141716. Differentiating CPCs were also coincubated with HU­
210 and the proteasome inhibitor MG132, which abolished the HU-210-induced regulation of 
RhoA levels (Figure R1.6E). These results indicate that CB1R signaling promotes proteasomal 
degradation of RhoA in newborn pyramidal neurons. 
Finally, we also evaluated whether pharmacological stimulation of the CB1R affects RhoA protein 
levels in developing cortical neurons in vivo. We administered the synthetic cannabinoid agonist 
WIN55,212-2 or its vehicle to pregnant females in gestational day 17 and embryos were collected 
6 hours later. Cannabinoid administration resulted in a reduction of RhoA protein levels in 
embryonic cortical extracts (Figure R1.6F), without affecting the expression of RhoA, RhoB, Cdc42
or Rac1 (Fig. S1.4B). Considering that RhoB is highly expressed during cortical development, its 
homology and function redundancy with RhoA (Azzarelli et al. 2015), we also analyzed RhoB 
protein levels upon CB1R genetic and pharmacological manipulation. RhoB protein levels were 
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increased in Nex-CB1-deficient embryonic cortical extracts, whereas WIN-55,212-2 treatment in 
vivo, and HU-210 administration of CPCs in vitro, decreased RhoB levels (Fig. S1.6). 
R1.6. RhoA downregulation is sufficient to rescue siCB1-induced migration arrest 
The aforementioned findings indicate that CB1 silencing leads to RhoA protein accumulation 
in newborn pyramidal neurons. To test whether this effect underlies the migration defects of 
siCB1-electroporated cells, we coelectroporated a RhoA-directed shRNA (shRhoA) together 
with the siCB1. The efficacy of this shRhoA to decrease RhoA expression has previously been 
demonstrated (Pacary et al. 2011). As shown in Figure R1.7, knocking-down RhoA fully rescued 
CB1 silencing-induced migration arrest, and restored both the normal distribution of GFP+ cells 
along the different cortical compartments (Fig. R1.7B) as well as the adequate positioning of the 
cells within the CP (Fig. R1.7C). This observation provides evidence for the notion that RhoA 
accumulation upon CB1 knockdown underlies the impairment of neuronal migration. Cofilin is 
a canonic downstream effector of RhoA that promotes actin filament disassembly. Since F-actin 
depolymerization is required for neuronal migration −as it allows the continuous dynamic recycling 
of actin cytoskeleton− we tested the ability of a non-phosphorylatable form of cofilin (cofilinS3A) 
(Pacary et al. 2011), which constitutively depolymerizes F-actin, to rescue CB1 knockdown-evoked 
migration arrest. In utero coelectroporation of cofilinS3A at E14.5 rescued the siCB1-induced PN 
migration defects at E17 (Fig. R1.7A-C), and confirm that RhoA accumulation in CB1-deficient 
Figure R1.7. RhoA knockdown or expression of non-phosphorylatable cofilin rescues CB1 silencing-induced 
migration arrest . (A, B) Migration analysis of cortical neurons electroporated in utero with a control siRNA or siCB1 together or 
not with a shRhoA or a plasmid encoding a non-phosphorylatable form of cofilin [cofilinS3A] and a GFP expression plasmid at E14.5 
and analyzed 3 days later, at E17.5. Representative images are shown for the different conditions (A). GFP+ cell distribution in the 
indicated developing cortical areas and within the CP was quantified (B,C). n= at least 3 different embryos from different litters per 
condition. Graphs represent mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001 vs siRNA control-electroporated brains; #P < 0.05; ##P
< 0.01; ###P < 0.001 vs siCB1-electroporated brains. Scale bar: 100 μm. 
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cells compromises neuronal migration by altering actin cytoskeleton dynamics. 
We next examined whether the rescue of radial migration by RhoA downregulation results in a 
correct neuronal positioning in the adult cerebral cortex. Electroporated embryos that developed 
until P60 were analyzed for the distribution of GFP+ cells. We found that, while the majority of 
siCB1-electroporated brains showed SBH, normal neuronal lamination −and absence of SBH−
was observed in brains coelectroporated with shRhoA (Fig. R1.8A). Taken together, these findings 
demonstrate that preventing RhoA accumulation rescues the migration defects caused by CB1
silencing. 
R1.7. Migration deficits induced by transient CB1 knockdown during development 
increases seizure susceptibility in adulthood 
Similarly to human MCDs, experimentally-induced ectopic accumulations of cortical neurons 
are aberrantly wired to the cortical circuitry, thus leading to an overall increased susceptibility to 
seizures (Manent et al. 2009; Feliciano et al. 2011). In addition to the striking heterotopias, the 
functional contribution of the normocortex to the proepileptic phenotype has gained attention 
lately (Petit et al. 2014). We therefore studied whether migration deficits caused by in utero CB1
knockdown sensitizes the adult offspring to seizures induced by the convulsant pentylenetetrazole 
(PTZ). We administered subconvulsive doses of PTZ intraperitoneally every 10 minutes to young 
adult (P60) mice, and measured the latency and cumulative dose of PTZ necessary for generalized 
Figure R1.8. Transient CB1 knockdown in migrating pyramidal neurons increases seizure susceptibility in 
adulthood . (A) Representative images of GFP+ cells in adult mice (P60) subjected to IUE at E14.5 with siCB1 or control siRNA 
together with RhoA or control shRNA . GFP+ cell accumulation within the subcortical WM in siCB1/shControl condition is indicated 
(asterisk). (B,C) P60 mice subjected to IUE at E14.5 with siCB1 or siControl combined with shRhoA or control shRNAs as above 
were injected i.p. with PTZ (22.5 mg/Kg) every 10 minutes until generalized seizures occurred. The mean latency to the occurrence 
of generalized seizures is represented (B) and the cumulative PTZ dose necessary for the onset of generalized seizures was calculated 
(C). n= 10-14 mice per group. Graphs represent mean ± SEM. *P < 0.05; **P < 0.01 vs siControl-electroporated mice; #P < 0.05; ##P
< 0.01; vs siCB1-electroporated brains. Scale bar: 200 μm. 
72 
seizures to occur. PTZ susceptibility was significantly increased in siCB1-electroporated mice, as 
shown by the reduced latency and PTZ cumulative dose necessary to evoke generalized seizures 
(Fig. R1.8B,C). Importantly, the rescue of siCB1-induced neuronal migration arrest achieved by 
shRhoA coelectroporation also prevented the increase in seizure susceptibility (Fig. R1.8B,C). 
These observations indicate that developmental alterations generated by transient CB1 loss 
of function in migrating pyramidal neurons decrease seizure threshold in adult offspring, and 
that concomitant RhoA downregulation rescues both neuronal migration deficits and seizure 
susceptibility. 
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AIM 2: SUMMARY 
As presented in the Introduction, there is growing prevalence of cannabis-based therapies in 
numerous countries, with a wide and increasing array of usages. In addition, marijuana is the 
most commonly used recreational drug worldwide, and particularly, the most consumed during 
pregnancy in Western countries. However, cannabis consumption during pregnancy can exert 
deleterious consequences in the progeny, including anxiety, depression, psychosis risk, and 
cognitive or social impairments. A crucial role has been assigned to CB1 in the development of 
long-range axonal connectivity by regulating corticofugal axon navigation and fasciculation, as 
well as in the CSMN cell-fate acquisition. Hence, in this project we modeled prenatal cannabis 
consumption in mice to identify the particular neurodevelopmental substrate responsible for 
cannabinoid-induced functional alterations that remain overt in adulthood. Administration of 
THC was conducted during a restricted embryonic time window, coinciding with the active period 
of glutamatergic neuron generation in the telencephalon. We found an impairment in CSMN 
generation that correlates with long-lasting skilled motor functional alterations and susceptibility 
to epilepsy. To unequivocally assess the role of CB1R signaling in THC-induced alterations, we 
employed constitutive CB1-deficient mice, which were resistant to THC-induced developmental 
alterations. Next, by using a Cre-mediated, lineage-specific, CB1 expression-rescue strategy in 
a CB1-null background, we were able to selectively rescue the deficits in CSMN development 
characteristic of CB1-deficient mice and, in turn, fully restore the susceptibility to embryonic 
THC-induced cellular and functional deficits in adulthood. 
Alternatively, we also found that prenatal THC exposure induced an increase in seizure 
susceptibility that was mediated by CB1Rs present in both developing dorsal telencephalic 
pyramidal neurons and forebrain GABAergic neurons. Hence, targeting CB1Rs with the most 
prominent marijuana-derived psychoactive compound in a particular neuronal population and 
time frame during embryonic development can evoke remarkable long-lasting neurological 
alterations in the offspring. 
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AIM2. IMPACT OF PRENATAL EXPOSURE TO THC ON BRAIN’S DEVELOPMENT 
AND FUNCTION 
R2.1. Prenatal THC exposure interferes with cortical projection neuron 
development 
To investigate the impact of prenatal THC exposure on cortical development, and to avoid 
the confounding influence that the cannabinoid could exert during very early gestational stages 
(Galve-Roperh et al. 2013; Wang & Dey 2006), we administered one daily intraperitoneal injection 
of THC or its vehicle to pregnant wild-type dams from E12.5 to E16.5. To minimize potential off­
targets, a low dose of THC (3 mg/kg) was employed. Of note, maternal and neonate body weight 
was unaffected by THC treatment, thus indicating that the dose used did not induce deleterious 
effects on general physical status. As CB1R signaling is essential for CSMN specification (Díaz-
Alonso et al. 2012), the effects of embryonic THC exposure on the developing cortex were first 
assessed by quantifying the generation of SCPNs. Confocal immunofluorescence analysis of ER81, 
a bona fide marker of SCPNs (Molyneaux et al. 2007), was performed in the treated offspring 
at P20. The number of ER81+ neurons was decreased in THC-exposed animals when compared 
to their vehicle-treated controls (Fig. R2.1A,B). The impact of THC on CSMN development was 
also analyzed at the level of corticospinal axonal connectivity. For this purpose we carried out 
fluorescent retrograde labeling (Red RetroBeads) from the cervical spinal cord to unequivocally 
identify CSMNs (Arlotta et al. 2005) (Fig. R2.1C). Red-labeled somata in deep cortical layer V 
where shown to express ER81, thus confirming the validity of ER81 as an appropriate marker 
of CSMNs (Fig. R2.1D). More importantly, we also found a significant reduction in the number 
of labeled CSMN somata in THC-treated mice as compared to their controls, pointing to an 
alteration of CSMN development and subcerebral connectivity (Fig. R2.1E, F). 
R2.2. Prenatal THC exposure induces long-lasting alterations in skilled motor 
function and seizure susceptibility 
To examine the functional consequences of the impaired SCPN development induced by prenatal 
cannabinoid exposure, we first employed the skilled reaching test, which allows the dissection 
of CSMN-dependent motor function as reflected by the ability to retrieve a pellet of palatable 
food with a forelimb through a narrow slit (Tomassy et al. 2010). To rule out potential unspecific 
developmental alterations owing to maternal care deficits induced by THC administration 
(Calvigioni et al. 2014), we used CB1-/- females, devoid of the behavioral impact of THC, which 
were mated with heterozygous CB1+/- males. Therefore, we analyzed skilled motor function in 
the CB1+/- and CB1-/- offspring. CB1+/- mice have been shown to exhibit an increased efficacy of 
agonist-induced G protein-coupled receptor signaling, which becomes comparable to that of wild­
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Figure R2.1. Embryonic THC exposure 
impairs subcerebral projection 
neuron development . (A) Subcerebral 
projection neurons in embryonically vehicle-
and THC-administered mice at P15 were 
stained with an anti-ER81 antibody (n = 7 
and 5, respectively). (B) ER81+ cell number 
was quantified and referred to the total 
cell number (DAPI) per cortical column. 
(C) CSMNs were labeled by injecting 
retrogradelly-transported red fluorescent 
beads (RetroBeads) in the cervical spinal 
cord at P10. (D) Representative image 
showing RetroBead colocalization with 
the subcerebral projection neuron marker 
ER81. (E) Representative images of 
retrogradelly-labeled somata in cortical 
layer V at P15. (F) RetroBead-labeled 
somata per cortical column were quantified 
in vehicle- and THC-exposed mice (n = 5 
and 4, respectively). *P<0.05, **P<0.01 vs.
vehicle-treated mice. Scale bars: (A, E) 200 
µm (insets, 60 µm); (D) 10 µm. 
type CB1+/+ mice, thus supporting the validity of the experimental approach (Selley et al. 2001). 
THC-exposed CB1+/- animals showed a significant impairment in skilled motor function compared 
to their vehicle-treated counterparts (Fig. R2.2A). Remarkably, CB1-/- mice, which consistently 
with our previous report showed an impairment in this task compared to their vehicle-treated 
CB1+/- littermates (Díaz-Alonso et al. 2012), did not suffer from any worsening in their skilled 
motor performance upon THC exposure (Fig. R2.2A). Noteworthy, neither the number of trials 
(Fig. R2.2B) nor the success in unskilled conditions were changed among groups, ruling out 
generalized motivational or unspecific motor deficits. Corticospinal function was also assessed 
with the staircase test and, again, a decreased performance was evident in THC-exposed CB1+/-
mice when compared to their vehicle-treated controls (Fig. R2.2C). In addition, control CB1-/- mice 
scored worse than their CB1+/- littermates, and THC treatment did not affect significantly their 
ability to reach the pellets. Control quantifications of unskilled reaching did not show significant 
differences among groups (Fig. R2.2D). Altogether, these data demonstrate the CB1R dependency 
of embryonic THC-evoked motor alterations. 
Developmental THC administration induces alterations in synaptic connectivity and plasticity 
(Tortoriello et al. 2014; Mereu et al. 2003), but its long-lasting functional consequences and 
the contribution of specific neuronal subpopulations remain largely unknown. Therefore, we 
analyzed whether seizure susceptibility was affected in the adult offspring of THC-administered 
pregnant mice by using a PTZ administration paradigm. Noteworthy, latency to seizures was 
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Figure R2.2. Embryonic THC exposure 
impairs subcerebral projection neuron 
development . (A) Subcerebral projection 
neurons in embryonically vehicle- and 
THC-administered mice at P15 were stained 
with an anti-ER81 antibody (n = 7 and 5, 
respectively). (B) ER81+ cell number was 
quantified and referred to the total cell number 
(DAPI) per cortical column. (C) CSMNs were 
labeled by injecting retrogradelly-transported 
red fluorescent beads (RetroBeads) in the 
cervical spinal cord at P10. (D) Representative 
image showing RetroBead colocalization with 
the subcerebral projection neuron marker ER81. 
(E) Representative images of retrogradelly­
labeled somata in cortical layer V at P15. (F) 
RetroBead-labeled somata per cortical column 
were quantified in vehicle- and THC-exposed 
mice (n = 5 and 4, respectively). *P<0.05, 
**P<0.01 vs. vehicle-treated mice. Scale bars: 
(A, E) 200 µm (insets, 60 µm); (D) 10 µm. 
significantly decreased in prenatally THC-exposed CB1+/- mice as compared to their vehicle­
treated counterparts (Fig. R2.2E). Consequently, a reduced PTZ cumulative dose was required 
to induce generalized seizures in the THC-treated offspring (Fig. R2.2F). This effect of prenatal 
cannabinoid administration was reminiscent of the adult CB1-/- mice phenotype, which displays an 
increased seizure susceptibility in the kainic acid model (Monory et al. 2006; Ruehle et al. 2013). 
Importantly, we found no further enhancement of PTZ susceptibility in THC-treated CB1-/- mice 
with respect to their vehicle-treated counterparts, thus confirming the CB1R-specificity of THC 
action (Fig. R2.2F). Overall, the neuronal and functional analyses of prenatally THC-administered 
mice showed a similar phenotype to CB1-null mice, thus indicating that embryonic THC exposure 
interferes with the neurodevelopmental role of CB1R signaling. 
R2.3. Prenatal THC exposure transiently impairs CB1R signaling 
Given the functional similarities between embryonic THC exposure and CB1 genetic inactivation, 
we sought to analyze the consequences of prenatal THC administration on CB1 expression. CB1R 
protein levels, as determined by Western blot, were significantly downregulated in THC-treated 
embryonic brains at E17.5 when compared to controls (Fig. R2.3A,C). Notably, at a perinatal stage 
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(P2.5), CB1R levels returned to those of the vehicle condition (Fig. R2.3B,D), indicating that CB1Rs 
are altered only transiently in our embryonic THC exposure paradigm. 
The presence of functional plasma membrane-exposed CB1Rs was next analyzed by the 
binding of the radioactively-labeled synthetic CB1R agonist [3H]CP55,940. A clear reduction in 
cannabinoid binding was observed in the brains of THC-treated embryos at E17.5 (Fig. R2.3E,G), 
though its values recovered to the level of vehicle-treated animals by P2.5 (Fig. R2.3F,H). Overall, 
these findings support that embryonic THC administration transiently disrupts appropriate CB1R 
function in the developing brain. 
Figure R2.3. Embryonic THC exposure 
transiently downregulates CB1Rs .
(A-D) CB1R protein levels were determined 
by Western blot in brain samples at E17.5 
(A, C) and P2.5 (B, D) after THC or vehicle 
administration from E12.5 to E16.5. The 
optical density of CB1R band was quantified 
and normalized to β-actin [n = 9 and 6 (E17.5 
vehicle- and THC-treated brain samples, 
respectively); n = 7 and 7 (P2.5 vehicle- and 
THC-treated brain samples, respectively)]. 
(E-H) Radiolabeled CP55,940 binding 
was quantified in coronal brain sections 
at E17.5 (E, G) and P2.5 (F, H) [n = 4 and 
6 (E17.5 vehicle- and THC-treated brains, 
respectively); n = 8 and 8 (P2.5 vehicle- and 
THC-treated brains, respectively)]. **P<0.01 
vs. vehicle-treated mice. Scale bars, 2 mm. 
R2.4. Neuronal lineage-specific CB1 reexpression selectively rescues the behavioral 
traits of embryonic THC exposure 
To unequivocally determine the actions of embryonic THC administration upon specific 
neuronal populations, of we made use of a Cre-mediated, lineage-specific, embryonic CB1
expression-rescue strategy in a CB1-null background (Stop-CB1 mice) (Ruehle et al. 2013). The 
selective expression of CB1Rs in dorsal telencephalic glutamatergic neurons (Glu-CB1-RS mice) 
was achieved by expressing Cre under the regulatory elements of Nex locus (Ruehle et al. 2013). 
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In addition, we rescued CB1 expression in forebrain GABAergic neurons (GABA-CB1-RS mice) by 
using the Dlx5/6-Cre mouse line (Monory et al. 2006). As control, a global rescue of CB1 expression 
driven by EIIa-Cre (CB1-RS) was also used (Ruehle et al. 2013). Characterization of CB1R 
expression by immunofluorescence was performed in the different mouse lines (Fig. R2.4 and S2). 
Figure R2.4. Characterization of selective CB1 expression-rescue in dorsal glutamatergic neurons and forebrain 
GABAergic neurons . (A) Immunofluorescence analysis of CB1R reexpression driven by Nex (Glu-CB1-RS) (A3), Dlx5/6
(GABA-CB1-RS) (A4), or EIIa (CB1-RS) (A2) promoters in Stop-CB1 mice (A1) was performed in P2.5 coronal brain sections. (B) 
Cortical CB1R expression analysis in the same mouse strains was performed at P20 (B1-B4). (C) Double immunofluorescence 
was performed with anti-CB1R antibody combined with anti-VGLUT1 (C1-C4) or anti-VGAT (C1’-C4’) antibodies. Arrowheads 
point to glutamatergic CB1R signal, which is abundant in pyramidal neuron fibers at P2.5 (A), and to scarce immunopositive 
puncta corresponding to glutamatergic (VGLUT1-positive) terminals at P20 (B and C). Arrows point to the abundant CB1R signal 
corresponding to GABAergic (VGAT-positive) neurons within the hippocampal formation at P2.5 (A) and the mature cortex at P20 (B
and C). Scale bars: (A) 200 µm; (B) 50 µm (inset, 10 µm); (C) 5 µm. 
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In Stop-CB1 mice only background (non-specific signal) was detected, while in Glu-CB1-RS
and GABA-CB1-RS animals CB1R immunoreactivity was observed with a distinctive pattern of 
expression (Fig. R2.4A-C). Glu-CB1-RS mice at P2.5 revealed a significant CB1R expression in 
descending corticofugal axons, while in GABA-CB1-RS mice a prominent CB1R expression was 
observed in the immature hippocampal formation (Fig. R2.4A1-A4). Cortical CB1R expression 
at P20 in Glu-CB1-RS mice appeared as scarce immunopositive puncta, in agreement with 
the low expression of the receptor in mature projection neurons (Soltesz et al. 2015), while 
most CB1R expression corresponded to GABAergic interneurons (Fig. R2.4B1-B4). Double 
immunofluorescence with VGLUT1 and VGAT, presynaptic markers of glutamatergic and 
GABAergic terminals, respectively, further confirmed the selectivity of the CB1 expression-rescue 
strategy (Fig. 2.4C). Thus, in Glu-CB1-RS mice, the small puncta of CB1R did not colocalize with 
VGAT immunoreactivity, in agreement with their presynaptic location in glutamatergic neurons 
(Fig. R2.4C and Fig. S2). 
To assess the reestablishment of the neurobiological substrate of THC-induced alterations, we 
quantified the number of ER81+ cells in cortical layer V. Remarkably, in vehicle-treated Glu-CB1­
RS mice the number of deep-layer ER81+ cells per cortical column was significantly rescued when 
compared to Stop-CB1 animals, and, in concert, Glu-CB1-RS mice gained susceptibility to THC­
induced impairment of SCPN development (data not shown). 
Once the lineage selectivity of the CB1 expression-rescue strategy at the cellular level was proved, 
we investigated the functional impact of embryonic THC exposure in adulthood. THC or vehicle 
Figure R2.5. Selective CB1R 
expression-rescue restores functional 
alterations and reestablishes THC 
susceptibility in Stop-CB1 mice . (A, 
B) Skilled motor activity was assessed by 
the skilled pellet-reaching (A) and staircase 
(B) tests in adult CB1R-rescued mice [n= 15 
and 15 (Stop-CB1 vehicle- and THC-treated 
mice, respectively); n = 20 and 17 (CB1-RS
vehicle- and THC-treated mice, respectively); 
n = 9 and 6 (Glu-CB1-RS vehicle- and 
THC-treated mice, respectively); n = 5 and 
7 (GABA-CB1-RS vehicle- and THC-treated 
mice, respectively)]. (C, D) Seizure 
susceptibility to subconvulsive doses of PTZ 
was determined. Latency to seizures (C) and 
the cumulative dose of PTZ required (D) are 
shown [n = 13 and 19 (Stop-CB1 vehicle-
and THC-treated mice, respectively); n = 18 
and 19 (CB1-RS vehicle- and THC-treated 
mice, respectively); n = 9 and 5 (Glu-CB1-RS
vehicle- and THC-treated mice, respectively); 
n = 9 and 8 (GABA-CB1-RS vehicle- and 
THC-treated mice, respectively)]. *P<0.05, 
**P<0.01 vs. corresponding Stop-CB1 
mice; #P<0.05, ##P<0.01 vs. corresponding 
vehicle-treated group. 
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was administered to dams coming from matings of females Stop-CB1 with Nex-Cre;Stop-CB1
(Glu-CB1-RS) or Dlx5/6-Cre;Stop-CB1 (GABA-CB1-RS) males, and their respective offsprings 
were analyzed at an adult age. CB1 reexpression in Glu-CB1-RS mice, but not in GABA-CB1-RS
mice, rescued the skilled motor deficits of Stop-CB1 mice as assessed by both the skilled-reaching 
test (Fig. R2.5A) and the staircase test (Fig. R2.5B). Global rescue of CB1 expression in CB1-RS mice 
also fully overcome the skilled motor deficits observed in Stop-CB1 mice. Notably, as expected, 
prenatal THC-treatment elicit significant skilled motor deficits exclusively in Nex-CB1-RS and 
CB1-RS (Fig. R2.5A,B). Hence, CB1 expression-rescue in dorsal telencephalic glutamatergic 
neurons is necessary and sufficient to confer THC susceptibility to corticospinal motor function. 
Finally, we also analyzed PTZ-induced seizure susceptibility in the various CB1 expression­
rescued mice. The seizure-prone phenotype of Stop-CB1 mice was partially restored in both Glu­
CB1-RS and GABA-CB1-RS, and this effect was more remarkable when CB1 was reexpressed 
systemically in CB1-RS mice (Fig. R2.5C,D). Remarkably, upon THC administration Stop-CB1, 
Glu-CB1-RS and GABA-CB1-RS mice were statistically indistinguishable and only CB1-RS mice 
retained a significant increase in seizure latency and PTZ cumulative dose compared to THC-
exposed Stop-CB1 mice. Notwithstanding, THC-exposed CB1-RS mice showed a significant 
increase in seizure susceptibility compared to vehicle-treated counterparts (Fig. R2.5C,D). These 
findings support the notion that prenatal CB1R signaling in both glutamatergic and GABAergic cell 
lineages is required for the appropriate balance of neuronal activity and overall brain excitability. 
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AIM1. ROLE OF THE ECS ON PYRAMIDAL NEURON RADIAL MIGRATION AND 
LONG-LASTING CONSEQUENCES OF DEVELOPMENTAL CB1R DYSFUNCTION 
Overall, the findings corresponding to the first Aim of this Thesis reveal an unprecedented 
pivotal role of the cannabinoid CB1R signaling in the adequate migration and positioning of 
cortical pyramidal neurons, whose dysfunction can trigger profound and long-lasting alterations 
in brain function. It has been long assumed that adult CB1-deficient mice have increased seizure 
susceptibility owing to the loss of eCB-dependent retrograde suppression of glutamate release 
from excitatory terminals (Katona & Freund 2008; Soltesz et al. 2015). Of note, our evidence adds 
to this classical view by demonstrating that developmentally restricted loss of CB1R function also 
increases seizure susceptibility, likely by causing aberrant positioning of cortical neurons, thus 
conceivably affecting their wiring and sensitizing the resulting circuitry to epileptogenesis. 
The classical idea sustains that the heterotopias are at the functional core of the characteristic 
hiperexcitability of MCDs, however, recent findings challenge this assumption and point to 
the involvement of the normotopic cortex as the major contributor to epilepsy (Cid et al. 2014; 
Petit et al. 2014). Another mechanism likely involved in the seizure-prone phenotype of siCB1­
electroporated mice may be that mispositioned pyramidal neurons lead to an aberrant recruitment 
of GABAergic interneurons to the developing cortex (Lodato et al. 2011). It is plausible to assume 
that, upon developmental CB1R dysfunction, both the SBH and normotopic cells abnormally 
recruit interneuron subpopulations which, in turn, alter the excitatory/inhibitory balance or 
display altered wiring. Anyhow, the identification of the precise mechanisms responsible for the 
proepileptogenic phenotype require further investigation. 
Neuronal migration is largely dependent on the dynamic regulation of the cytoskeleton (Nguyen 
& Hippenmeyer 2014). Actin cytoskeleton remodeling plays a fundamental role in this process, and 
the inhibition of RhoA function is a common feature of different promigratory pathways (Hand et 
al. 2005; Pacary et al. 2011; Tang et al. 2014; Azzarelli et al. 2014). The expression pattern of RhoA 
in the developing cortex, with high abundance in the VZ/SVZ and very low –if any– levels in the 
IZ and CP (Azzarelli et al. 2015), suggests that, from a cell-autonomous perspective, this protein 
is deleterious for pyramidal neuron migration, as demonstrated in a recent report (Cappello et al. 
2012). RhoA ubiquitination and degradation plays an important role in the regulation of neuronal 
cell morphology (Bryan et al. 2005) and affects cancer cell migration (Nethe & Hordijk 2010). 
However, to the best of our knowledge, this is the first study that identifies a specific role of the 
proteasomal degradation of RhoA in the promotion of neuronal migration. 
Taking into account the complementary expression pattern of both CB1 and RhoA in the 
developing cortex, it is conceivable that CB1R-mediated RhoA degradation ensures a complete 
clearance of the remaining RhoA protein in newborn neurons to allow their migration. Our 
results are also in line with previous findings supporting that the actin cytoskeleton is a major 
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target of CB1R signaling in developing neurons (P. Berghuis et al. 2007; Oudin et al. 2011; Roland 
et al. 2014; Njoo et al. 2015). In addition, CB1R activation can reduce RhoB protein levels, and 
therefore we cannot exclude a potential contribution of this related GTPase in CB1R-dependent 
neuronal migration. Additionally, this observation raises the possibility that CB1R-dependent 
proteasomal degradation is a promiscuous mechanism affecting different Rho GTPases with 
interesting implications for a variety of cellular processes, but this remains to be explored. 
We found that the migration defects caused by CB1 silencing affect more dramatically a subset of 
the targeted GFP+ cells. This might be related to the unequal knockdown efficacy among targeted 
cells and/or to the heterogeneity of a neuronal population in their capacity to compensate the loss 
of a given promigratory mechanism, as it occurs with other systems (Heng et al. 2008; Feliciano 
et al. 2011; Zheng et al. 2012; van den Berg et al. 2016). Similarly, in humans, MCDs frequently 
affect only relatively small neuronal populations, even when caused by germline mutations (Lim 
& Crino 2013; Barkovich et al. 2012). Interestingly, a recent study supports that the migration 
deficits caused by Dcx shRNA are due to off-target effects of such manipulation onto endogenous 
miRNAs (Baek et al. 2014). Nonetheless, the specificity of our CB1R genetic knockdown strategy 
and its consequences on radial migration are validated by the comparable phenotypes observed 
when using CB1 siRNA, CB1 shRNA, and Cre-mediated ablation of CB1 in CB1f/f mice. Noteworthy, 
the severe migration defects observed upon acute CB1 knockdown are notably subtler upon 
constitutive CB1 mutation (Fig. S1.3A,B) and do not result in the formation of heterotopias. This is 
most likely due to compensatory mechanisms occurring in germline or lineage-specific knockout 
mice, as also occurs for other migration regulatory proteins such as Dcx (Bai et al. 2003), amyloid 
precursor protein (Young-Pearse et al. 2007), and EF-hand domain-containing protein 1 (de Nijs 
et al. 2009). 
A wide variety of neurodevelopmental diseases are caused by the disruption of neuronal migration. 
Understanding the biological mechanisms responsible for a finely tuned corticogenesis emerges 
as a key requisite for the elaboration of rational therapeutic strategies for the consequences of 
MCDs, including epilepsy and neuropsychiatric disorders. Notably, a genetic origin has been 
identified for some human diseases caused by neuronal migration alterations, and the genes 
identified in such diseases correspond, in most cases, to cytoskeletal or cytoskeleton-regulatory 
proteins (Barkovich et al. 2012), however, mutation of most of the genes so far identified in human 
patients fail to mimic the phenotypes in mouse models (Cappello 2013). 
Given this conceptual frame, the implications of the malfunctioning of the eCB system in the 
origin of neurodevelopmental disorders caused by cell migration defects are exciting perspectives 
for future research. Remarkably, evidences in the literature associate genetic alterations (i.e., 
copy number variations) and gene polymorphisms of some of the eCB system elements as CNR1, 
DAGLA, NAPEPLD, ABHD12, or CNRIP1, with the occurrence of human diseases, such as autism 
spectrum disorders and intellectual disability, or the polyneuropathy, hearing loss, ataxia, 
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retinitis pigmentosa and cataract syndrome named as PHARC (Fiskerstrand et al. 2010; Bragin 
et al. 2014). Particularly, the CB1R-encoding CNR1 gene has been put forward as a strong autism­
related candidate gene, given the increased status of de novo mutations in this gene in samples 
from a cohort of 2588 autistic patients (Girirajan et al. 2013) or the strikingly high probability 
of CNR1 haploinsufficiency (Huang et al. 2010). In agreement with these indications, CB1R 
signaling regulates neuronal identity by controlling the transcriptional factor axis Ctip2-Satb2 
(Díaz-Alonso et al. 2012), that together with Tbr1, is responsible for neuronal connectivity deficits 
that associate with mental retardation and autism (Carpentier et al. 2013; Deriziotis et al. 2014; 
Huang et al. 2014). 
Alterations of multiple cellular mechanisms frequently converge in the pathogenesis of MCDs, 
and an unbalanced activity of CB1R signaling can affect cortical development by interfering with 
several processes in addition to neuronal migration (Diaz-Alonso et al. 2012). While SBH is 
most frequently originated from abnormal neuronal migration, some neocortical heterotopias 
are associated with ectopic progenitor cell divisions (Kielar et al. 2014). CB1R signaling controls 
the activity of the PI3K/mTORC1 pathway, both in neuronal precursors (Díaz-Alonso et al. 
2014) and in mature neurons (Puighermanal et al. 2009), and the deregulation of this signaling 
route is at the origin of some focal MCDs, in particular tuberous sclerosis, type 2 focal cortical 
dysplasia, and megalencephaly (Lim & Crino 2013). Notably, mTORC2 signaling has been shown 
to control actin cytoskeleton by modulating Rho-GTPases and dysregulation of the complex is 
associated to a variety of neurodevelopmental pyschiatric disorders (Jacinto et al. 2004; Costa-
Mattioli & Monteggia 2013). Despite there are no evidences to the date relating CB1R signaling 
with mTORC2 activity, a putative connection between both signaling platforms is an option that 
is worth tackling. 
Beyond genetic alterations in elements of the cannabinoid signaling machinery, environmental 
insults can also affect CB1R-dependent neuronal migration. In particular, prenatal exposure to 
the cannabinoids present in marijuana has been shown to affect fetal development in both mice 
and humans (Hurd et al. 2005; Jutras-Aswad et al. 2009; Tortoriello et al. 2014). Detrimental 
consequences in executive function have been reported in studies following children from mothers 
that smoked marijuana during pregnancy (Fried & Smith 2001; Smith et al. 2004), although the 
neurobiological substrate of these changes remains largely unknown. Altered CB1R signaling 
induced by long half-life phytocannabinoids may eventually interfere with neuronal migration, 
as previously shown for synthetic cannabinoids (Saez et al. 2014). Likewise, given the capacity 
of sustained CB1R stimulation to induce transient CB1R downregulation –thus short-term CB1
loss of function– gestational cannabinoid exposure may disturb cortical laminarization and cause 
changes in social behavior and cognition (Diaz-Alonso et al. 2012). Cannabinoids have a great 
potential as medicines owing to the broad distribution of their receptor targets throughout the 
body and pleiotropic functions, together with their high safety and fair tolerability (Mechoulam et 
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al. 2014; Pertwee 2012). In particular, CBD, the most relevant nonpsychoactive phytocannabinoid, 
has recently received a huge attention as a promising pharmacological tool for the management 
of refractory pediatric epilepsies, such as the Dravet and Gaston-Leroux syndromes (Devinsky 
et al. 2014). However, as our study and other pieces of evidence support (Maccarrone et al. 
2014), cannabis intake, for both therapeutic and recreational use, must be exquisitely controlled 
if not absolutely discouraged during pregnancy or critical ontogenic periods in order to avoid 
interferences with the crucial role played by CB1Rs during brain development. 
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AIM2. IMPACT OF PRENATAL EXPOSURE TO THC ON BRAIN’S DEVELOPMENT 
AND FUNCTION 
The evidence shed by the second Aim of this Thesis reveals that THC administration during 
pregnancy exerts long-lasting consequences in the offspring owing to a transient disruption of 
CB1R signaling that impedes the adequate temporally and spatially confined function of the 
receptor in neuronal development. Remarkably, the deleterious consequences of prenatal THC 
exposure in the progeny are independent of the classical neuromodulatory role of CB1R signaling 
in the adult brain and emerge as a consequence of the transient disruption of physiological CB1R 
signaling during prenatal development, before synaptic neuronal activity is established. These 
findings provide previously unidentified preclinical evidence for the risk of cannabis consumption 
during pregnancy. Cannabis is, by far, the most commonly consumed illicit drug during pregnancy 
in Western countries, and therefore its use constitutes a considerable public health issue. Over the 
last few decades, longitudinal studies on human cohorts (Volkow et al. 2014; Fried & Smith 2001), 
as well as research using animal models (Schneider 2009), have addressed the impact of early 
cannabinoid exposure in adulthood. The majority of these studies suggest that early cannabinoid 
exposure sensitizes the CNS to cognitive impairments, increases the risk of neuropsychiatric 
disorders such as schizophrenia and anxiety, induces cross-generational epigenetic modifications 
and enhances drug-addiction susceptibility (Szutorisz et al. 2014; Sonon et al. 2015; Rubino 
et al. 2015; Szutorisz & Hurd 2016). Noteworthy, there are confounding factors affecting the 
interpretation of these results as the outcome of maternal cannabis consumption on infant 
behavior or cognition are inconsistent among different studies, and some crucial variables are 
often excluded. Therefore, conclusions driven from them should be taken with caution (Rogeberg 
2013; Huizink 2014; Volkow & Baler 2015). Our findings show that exposure to relatively low 
doses of THC in a narrow temporal window during prenatal development negatively impacts 
mouse cortical development, and this, in turn, has long-term functional consequences on the 
mature offspring. Specifically, we unequivocally identify the pool of CB1Rs located on developing 
cortical glutamatergic neurons as the sole reason for the deficits in corticospinal function induced 
by embryonic THC exposure. 
The CB1R plays a pivotal neurodevelopmental role by transducing information from the 
endocannabinoid ligands present in the neurogenic niche into the coordination of the intrinsic 
developmental program of developing neurons (Diaz-Alonso et al. 2012; Galve-Roperh et al. 2013). 
In agreement, early developmental exposure of chicken embryos to a THC analog (Psychoyos 
et al. 2008) and genetic manipulation of the CB1R-interacting protein CRIP1 in Xenopus 
laevis development (Zheng et al. 2015) have been shown to disrupt the appropriate balance of 
transcription factors that intrinsically drive neural development. Thus, CB1R signaling refines 
the molecular, laminar, and hodology of projection neurons in the cerebral cortex (Maccarrone 
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et al. 2014; Diaz-Alonso et al. 2012). The present findings support that sustained exposure to 
THC may act as a functional suppressor of CB1R signaling, as THC interferes with developmental 

CB1 function in a transient but functionally impacting manner. Therefore, prenatal cannabinoid 

exposure recapitulates the long-term structural and functional deficits in corticospinal connectivity 
previously demonstrated in CB1 knockout mice (Díaz-Alonso et al. 2012). The susceptibility of 
axonal connectivity to CB1 loss of function may persist at later developmental stages in susceptible 
areas and critical periods, as it has been demonstrated that THC consumption in adolescents can 
also result in axonal connectivity deficits (Zalesky et al. 2012). Nevertheless, in another study, 
daily marijuana consumption did not induce volumetric changes in white matter nor several brain 
areas (Weiland et al. 2015). 
Our findings are in partial agreement with a previous study reporting that chronic prenatal 
THC administration alters neuronal connectivity by disrupting cytoskeletal dynamics in motile 
axons. Specifically, prolonged THC administration (from E5.5 to E17.5) was shown to disrupt 
cannabinoid signaling, interfering with MAGL and DAGLα –enzymes responsible for 2-AG 
metabolism– and also induced CB1R downregulation (Tortoriello et al. 2014). However, in that 
study, the functional consequences of chronic prenatal THC administration on axonal projections 
were not determined, instead they focused on characterizing axon fasciculation abnormalities. 
Manipulation of endocannabinoid levels in perinatal stages by chronic pharmacological inhibition 
of FAAH, the main anandamide-degrading enzyme, induced depressive and cognitive impairment 
traits, despite the fact that no specific neuronal development alterations could be demonstrated 
(Wu et al. 2014). On the other hand, pharmacological inhibition of MAGL increased 2-AG levels 
that, acting on CB2Rs present on oligodendrocytes, induced axon fasciculation alterations by 
interfering with Slit2/Robo1 signaling, although the functional consequences of these actions 
remain unknown (Alpár et al. 2014). Other studies have also shown that perinatal cannabinoid 
administration induces cognitive deficits that can be linked to neuronal transmission adaptations, 
particularly plasticity of glutamatergic neuron activity and aberrant synaptic organization (Mereu 
et al. 2003; Antonelli et al. 2005; Bernard et al. 2005; Rubino et al. 2015). Thus, whereas it is 
already known that postnatal cannabinoid exposure may have negative consequences on some 
neurological functions in the adult brain (Volkow et al. 2014), our findings unveil long-lasting 
functional brain alterations induced by restricted prenatal cannabinoid administration that can 
be unequivocally ascribed to specific developing neuronal lineages. Notably, the results shown 
above reveal a direct impact of THC administration on the developing embryo that does not rely on 
indirect consequences of maternal programming and that is evident without the requirement of a 
second hit, as proposed for cannabis-induced risk of psychosis (Calvigioni et al. 2014). In any case, 
translating the long-term implications of developmental cannabis exposure into humans requires 
a very stringent control of confounding factors (Rogeberg 2013; Volkow & Baler 2015), and this is 
more important when analyzing cognitive and psychiatric traits than merely determining motor 
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performance or general brain excitability. 
In addition to corticospinal motor function alterations, embryonic THC exposure increased 
seizure susceptibility in adult mice, even when CB1Rs return to normal levels shortly after 
cessation of THC exposure. The neuromodulatory role of CB1Rs in the mature brain act as a 
synaptic circuit breaker (Katona & Freund 2008; Soltesz et al. 2015), crucial for the control of 
brain excitability. Accordingly, acute treatment with THC exerts anticonvulsant effect in various 
models (Karler et al. 1974; Turkanis et al. 1979). In addition, great interest has recently emerged 
in the potential application of cannabis preparations enriched in CBD for the management of 
pediatric epilepsy disorders such as Dravet and Gaston-Leroux syndromes (Devinsky et al. 2014). 
However, results presented herein demonstrate that THC interferes with the developmental 
role of CB1 and induces a proepileptogenic neural circuitry configuration independently of its 
neuromodulatory role in the adult brain. 
Our CB1 expression-rescue experiments show that the THC-induced increase in seizure 
susceptibility relies on alterations not only of PNs but also of GABAergic neurons, supporting 
a specific role of CB1 in the development of forebrain GABAergic neurons. In one (not very 
convincing) study, the authors claimed that prenatal THC increases CCK+ interneuron density 
in the hippocampus (Berghuis et al. 2005), whereas in a posterior study from the same group 
they describe a contrasting effect of diminished hippocampal CB1R+ basket cell innervation 
(Tortoriello et al. 2014). Notably, our results are more easily reconcilable with the second case, 
whereby prenatal cannabinoid exposure leads to an inhibitory deficit that likely accounts for the 
proepileptogenic phenotype of THC-exposed GABA-RS mice. 
Further investigations are required to underscore the potential contribution of these, and 
perhaps other, neuronal lineages targeted by prenatal cannabinoid exposure. Anyhow, our 
preclinical observations support that although cannabis preparations can exert anticonvulsive 
actions in children and adults, they could also enhance the risk of seizures –by suppressing CB1R 
function– when administered before birth, thus raising a note of caution that might be considered 
when the potential therapeutic uses of cannabinoid-based medicines are defined and regulated 
for pregnant women. 
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CONCLUSIONS & PERSPECTIVES
 
The accumulated evidences harvested during the process of this Doctoral Thesis allow us to 
delineate the main conclusions of this work. 
I) The CB1 cannabinoid receptor tightly controls the process of radial migration of newborn 
pyramidal neurons during mouse embryonic development. 
II) Engagement of CB1Rs by endocannabinoids in newborn pyramidal neurons ensure 
the required cell-autonomous withdrawal of RhoA to endure radial migration and final 
positioning within the cerebral cortex. 
III) Subchronic administration of THC (for 5 consecutive days) at a dose of 3 mg/Kg consistently 
induces a substantial downregulation of CB1Rs that mimics the phenotypic traits of CB1
genetic deficiency. Therefore, this developmental, temporally-restricted protocol constitutes 
a useful tool to interrogate the developmental CB1-specific functions and the functional 
outcome of their disruption. 
IV) Prental exposure to THC interferes with the developmental role of CB1 and induces a 
proepileptogenic neural circuitry independently of its neuromodulatory role in the adult 
brain. 
V)	 Developmental CB1R signaling safeguards proper corticogenesis, since genetic or 
pharmacological manipulations lead to profound and long-lasting cellular and functional 
alterations in the progeny, with particular relevance for the skilled motor performance and 
overall brain excitability. 
VI)	 Alterations of the embryonic ECS function might be responsible, or contribute to some 
Malformations of Cortical Development (MCDs) with increased epileptogenesis. 
Uncountable questions rise in view of these results that deserve proper research, and hopefully, 
an answer. 
For instance, it would be quite interesting to evaluate whether embryonic THC-dependent CB1R 
downregulation may have an impact on the process of pyramidal neuron radial migration, as we 
observed with genetic downregulacion. 
Additionally, go further into the cellular and molecular mechanisms responsible of the increased 
seizure susceptibility in the case of both genetic and pharmacological manipulation, as well as to 
address whether there is a real contribution of SBH to the phenotype, is a noteworthy issue. 
To finish, finely dissect the functions of the different CB1R pools (i.e. CB1Rs expressed by 
different neuronal subpopulations) and their precise contribution to the observed –and other– 
phenotypic manifestations of prenatal ECS dysfunction, ensure a long way in the exciting field of 
research on the role of the Endocannabinoid System during mammalian brain development. 
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SUPPLEMENTARY FIGURES
 
Aim 1: Role of the ECS on pyramidal neuron radial migration and long-lasting 
consequences of developmental CB1R dysfunction . 
Figure S1 .1 . CB1 siRNA-mediated 
neuronal migration arrest operates 
in different pyramidal neuron 
lineages . (A, B) Migration analysis of 
cortical neurons electroporated in utero
with siCB1 or a control siRNA together 
with a Gfp expression plasmid at E14.5 
and analyzed at E16.5. Representative 
images and neuronal quantification in 
the indicated cortical compartments 
are shown. (C, D) Migration analysis of 
CB1f/f cortical neurons electroporated in 
utero with Cre or a control Gfp at E13.5 
and analyzed at P2. (E-G) Morphological 
assessment of primary cortical neurons 
electroporated with siCB1 or control 
siRNA at E14.5 and maintained in 
differentiation conditions for 4 DIV. 
The number of primary neurites and the 
mean neurite length were calculated. (H, 
I) Migration analysis of cortical neurons 
electroporated in utero with siCB1 or 
siControl together with a Gfp expression 
plasmid at E13.5 and analyzed at E16.5. n= 
at least 3 different embryos from different 
litters per condition and 3 independent 
experiments with at least 100 GFP+ cells 
from 6 imaging fields for morphological 
experiments in vitro. Graphs represent 
mean ± SEM. *P < 0.05; **P < 0.01; ***P
< 0.001. Scale bars: A, C, H, 50 μm; E, 
15 μm. 
Figure S1.2 .Selectivity of conditional 

Dcx-driven Cre expression plasmid .
 
(A) E14.5 cortical neurons were 
electroporated ex utero with a Dcx-driven
Cre expression plasmid with intrinsic 
GFP, together with a CaMKIIa-driven 
mCherry expression plasmid, in order to 
speciffically address GFP, mCHERRY and 
Cre expression restricted to postmitotic 
principal neurons. (B-C) A Dcx-driven
Cre expression plasmid with intrinsic 
GFP was electroporated in utero and 
embryos analized at E17.5. Codistribution 
analysis of the proliferative marker PCNA 
along with intrinsic Dcx-GFP expression 
(B) or with Dcx-driven Cre expression (C) 
were performed. Representative images 
are shown. Scale bars: A, 10 μm; B, C, 40 
μm (insets 20 μm). 
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Figure S1.3 . CB1 regulation of 
radial migration is postmitotic 
and does not involve changes 
in cell survival . (A, B) Analysis 
of the migration of BrdU+Ki67- 
cells at E16.5 in CB1-/- embryos 
and their CB1+/+ littermates 
injected with BrdU at E14.5. (C, 
D) Immunofluorescence analysis 
of cleaved caspase-3 (CC-3) and 
TUNEL staining in siCB1 and 
control siRNA-electroporated 
brains. DNase treated sections 
were employed as positive control 
in TUNEL analysis. n= 4 embryos 
per genotype for each experiment. 
Graphs represent mean ± SEM. *P 
< 0.05. Scale bars: A, C 100 μm; 
D, 20 μm. 
Figure S1.4 . CB1 receptor manipulation does not affect RhoA, RhoB, Cdc42 or Rac1 mRNA expression . (A) qPCR 
analysis of the expression levels of RhoA, RhoB, Cdc42 and Rac1 in E17.5 Nex-CB1-/- and CB1f/f embryonic cortices. (B) qPCR analysis 
of the expression levels of RhoA, RhoB, Cdc42 and Rac1 in E17.5 WIN 55,212-2-treated embryonic cortices. n= at least 3 different 
embryos per group. Graphs represent mean ± SEM. 
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Figure S1.5. Differentiation of adherent 
cortical progenitor cell (CPC) cultures can 
model the cellular context of migrating 
neurons in the developing cerebral cortex .
(A, B) Characterization of the CPC cultures in 
proliferation and differentiation conditions. 
The expression of Pax6 and Tuj1 was analyzed 
in order to identify their radial glial-like dorsal 
telencephalic progenitor identity and their ability 
to undergo neuronal differentiation, respectively. 
(C-E) qPCR analysis of the expression levels 
of nestin, CB1 and RhoA in proliferating 
vs differentiating CPCs. n= 3 independent 
experiments. Graphs represent mean ± SEM. *P
< 0.05; ***P < 0.001. Scale bars: 25 μm. 
Figure S1.6 . CB1 signaling controls RhoB protein levels in pyramidal neurons . (A) RhoB protein levels were determined 
by Western blot in cortical tissue derived from E17.5 Nex-CB1-/- and CB1f/f littermates; E17.5 embryos exposed to the CB1R agonist 
WIN 55,212-2 (5 mg/Kg) or its vehicle for 6 hours and HU-210 (50 nM) or its vehicle for 6h in primary differentiating CPCs. Loading 
control was performed with anti α-tubulin antibody. n= at least 3 different embryos per genotype or treatment, and 3 independent 
CPC cultures. 
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Aim 2: Impact of prenatal exposure to THC on brain’s development and function . 
A 
B 
Figure S2. Characterization of selective CB1 expression-rescue in dorsal glutamatergic neurons and forebrain 
GABAergic neurons of adult mouse hippocampus . (A) Immunofluorescence analysis of CB1R reexpression driven by Nex
(Glu-CB1-RS), Dlx5/6 (GABA-CB1-RS), or EIIa (CB1-RS) promoters in Stop-CB1 mice was performed in P20 coronal brain sections. 
(B) Double immunofluorescence was performed with anti-CB1R antibody (red) combined with anti-VGLUT1 (green) or anti-VGAT 
(blue) antibodies. Arrowheads point to scarce immunopositive puncta corresponding to glutamatergic (VGLUT1-positive) terminals in 
CA1 at P20. Arrows point to the abundant CB1R signal corresponding to GABAergic (VGAT-positive) neurons within the hippocampal 
CA1 at P20. Scale bars: (A) 200 µm; (B) 20 µm (inset, 5 µm) 
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